Diagnosing tuberculosis among 609 adolescents (aged 12-18 years) with symptoms suggestive of tuberculosis at the Palamaner diagnostic Centre, South India by Uppada, Dharma Rao
1 
 
Diagnosing tuberculosis among 609 adolescents (aged 12-18 years) 
with symptoms suggestive of tuberculosis at the Palamaner 
diagnostic Centre, South India 
 
 
Dharma Rao Uppada 
 
 
Centre for International Health  
Faculty of Medicine and Dentistry 
University of Bergen, Norway 
St. John’s Research Institute, Bangalore, India 
2012 
 
 
 
 
 
 
2 
 
Diagnosing tuberculosis among 609 adolescents (aged 12-18 years) 
with symptoms suggestive of tuberculosis at the Palamaner 
diagnostic Centre, South India 
 
 
Dharma Rao Uppada 
 
 
This thesis is submitted in partial fulfilment of the requirements for the degree of Master of 
Philosophy in International Health at the University of Bergen.  
 
 
 
Centre for International Health  
Faculty of Medicine and Dentistry 
University of Bergen, Norway  
St. John’s Research Institute, Bangalore, India 
2012 
 
 
 
 
 
3 
 
ACRONYMS AND ABBREVIATIONS 
ARTI  Annual risk of Tuberculosis infection 
BCG  Bacillus Calmette-Guérin 
BMI  Body Mass Index 
DGW  Diagnostic ward 
DHEA  Dehydro-epiandrosterone 
DOTS  Directly observed treatment short course 
HIV  Human immune virus 
IGRA  Interferon Gamma Release assays 
LJ – Medium Lowenstein – Jensen Medium 
LTBI  Latent tuberculosis infection 
MDR TB Multi drug resistant TB 
MGIT  Mycobacterium growth indicator tube 
MOTT  Mycobacterium other than tuberculosis 
NFHS  National family health survey 
NTM  Non Tuberculous Mycobacteria 
PCR  Polymerase chain reaction 
QFT  QuantiFERON 
r RNA  ribosomal Ribo-Nucleic Acid 
RNTCP Revised National Tuberculosis Control Programme 
TB  Tuberculosis 
TH1 & TH2 T- Helper cells 1 & 2 
TST  Tuberculin Skin Test   
WHO  World Health Organization 
Z – N staining Zeil – Neelsen staining 
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Abstract 
 
Background: 
Tuberculosis (TB) accounts for 1.7 million deaths, according to the recent WHO report. India 
alone accounts for one fifth (21%) of all the TB cases globally. Mycobacterial pathogens are 
classified into Typical Mycobacteria and Atypical Mycobacteria. Studies have shown that 
adolescents are a vulnerable age group having higher chance of getting pulmonary TB 
infection and disease compared to younger children and adults. This age group is a target 
group for vaccination.  
 Objectives: 
• To estimate the proportion of definite TB and probable TB in 12-18 year old 
adolescents.  
• To estimate the rate of Nontuberculous Mycobacteria (NTM) in the same group. 
Methods: 
The present study is part of a prospective, observational two year cohort study conducted 
among school/ college going adolescents, 12-18 years in Palamaner taluk, South India during 
February 2007 to July 2010. A total of 609 participants attended the diagnostic ward with any 
of the criteria for referral. The sputum specimens were examined by concentrated AFB smear 
microscopy and processed for culture. Written informed assent from the subjects and consent 
from the parents or guardians was obtained at the time of enrollment of the participant before 
the start of the procedures. 
Results: 
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During the 2 years follow-up of 6643 participants, 609 participants attended the diagnostic 
ward (DGW) for Tuberculosis testing.  Among all these participants, 310 (50.9%) were males 
and 299 (49.1%) participants were females.  443 (72.9%) participants were referred to DGW 
based on TST positivity (greater than or equal to 10 mm). A total number of 7 (1.15 %) 
participants were diagnosed as definite TB, 3 (0.50 %) participants were diagnosed as 
probable TB. The proportion of 19.05% participants had NTM positive sputum samples. 
Participants having cough for equal to greater than 2 weeks were, 19 times more likely to 
become positive for M.tb growth of sputum sample (O.R = 18.60; 95% C.I = 4.02 – 86.05). 
There was 2 times greater chance of isolating NTM from participants who belongs to Dalit/ 
Harijan’s community.  
Discussion: 
The proportion of the cases detected in our study was less compared to the estimation by 
Revised National Tuberculosis Control Programme (RNTCP), in 2007 and what other studies 
had shown. Most of the participants those referred to diagnostic ward did not show up for TB 
tests. We consider that, the NTM species isolated in our study are either by chance or by the 
contamination of sputum samples by environmental Mycobacteria. These isolates therefore 
had no clinical significance.  
Conclusion: 
Further studies need to be conducted to ascertain the actual burden of TB disease among all 
the adolescent age groups including people who don’t go to schools. There must be further 
studies to find out the clinical significance of NTM among the adolescent age groups. 
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1. Introduction and literature review: 
 
1.1: Global burden of TB: 
Tuberculosis (TB) accounts for 1.7 million deaths, according to recent WHO report (1), this 
ranks second to HIV as a cause of death globally. There were an estimated 14 million 
prevalent cases of TB globally, of this India accounts for nearly 1.6 to 2.4 million cases.(1). It 
was estimated that 9.4 million incident TB cases globally which was about 137 cases per 100 
000 population during 2009. Of these cases Asia accounts for 55% and Africa accounts for 
30%. It was estimated that out of 9.4 million incident cases in 2009, 1.1 million cases were 
HIV positive cases. Out of these 1.1 million HIV positive cases 80% were from Africa. There 
were 1.3 million deaths among HIV negative cases of TB and 0.4 million deaths among HIV 
infected cases in 2009. In 2008 it was estimated by WHO that 440 000 cases of multi drug 
resistant TB (MDR TB) were present. China, India, Russian federation and South Africa  had 
the largest number of estimated cases of MDR TB during 2008 (1).  The WHO fact sheet 
dated November, 2010 on tuberculosis, states that persons with TB disease can infect 10 to 
15 other persons on an average every year(2). One third of world’s population is infected 
with Tuberculosis. The new smear positive case notification globally was 2.6 million. and in 
India it was 0.6 million in 2009(1).   
 
1.2: Burden of TB in India: 
India alone accounts for one fifth (21%) of all the TB cases globally. The WHO estimates in 
2009 states that 2 million incident cases and 3 million prevalent cases of TB were present in 
India. Out of these 0.13 million incident TB cases were HIV positive during 2009. It was 
estimated that there were 0.28 million deaths due to Tuberculosis among HIV negative TB 
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patients during 2009 in India. 17% of the TB patients in India were known HIV positive 
patients during 2009. WHO estimates in India states that there were 1,660 cases of MDR-TB 
present during 2009. The new smear positive case notification in India was 0.6 million during 
2009(1). There were few studies on adolescent TB giving very little details about pulmonary 
tuberculosis during the adolescent (12 to 18 years) age group. The nationwide survey was 
done to know the prevalence of TB by National Tuberculosis Institute; Bangalore had shown 
the annual risk of infection was 1.5 and the prevalence of infection among 1-9 years age was 
8.2 %.(3) These studies have not given much importance to Adolescent age group. 
 
1.3: Non tuberculosis Mycobacteria (NTM):  
 
At present in genus Mycobacteria more than 125 species are identified excluding 
Mycobacterium tuberculosis and Mycobacterium leprae (4). Nontuberculous Mycobacteria 
(NTM) has been classified according to Runyon system of classification(5). This system of 
classification is becoming less important clinically, after the development of new molecular 
techniques of isolation of species, which includes 16S rRNA gene sequencing as a standard 
for isolation of NTM species (4, 6). Based on the guidelines provided by American Thoracic 
Society/ Infectious disease Society of America, the diagnosis of NTM infection can be done 
with the combination of clinical, radiological and Microbiological criteria(4). 
Mycobacterial pathogens were classified into Typical Mycobacteria and Atypical 
Mycobacteria (7-8) based on optimal speed of growth and chromogenicity (Runyon system of 
classification). 
 
1.3.1: Classification of Mycobacteria: 
1) Typical: M. tuberculosis, M. bovis, M. avium, M. leprae, M. africanum, M. simiae.  
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2) Atypical {Mycobacterium other than tuberculosis (MOTT) or Nontuberculous 
Mycobacteria (NTM)}  
 Group 1 (Photochromogens) 
  M.kansasii, M.marinum 
 Group 2 (Scotochromogens) 
  M.scrofulaceum (M.marianum), M.szulgai  
 Group 3 (Non Chromogens) 
  M.intracellulare, M.xenopi, M.ulcerans  
 Group 4 (Rapid growers) 
  M.fortuitum, M.chelonei 
 
The accurate prevalence of the NTM in India is not available. Majority of the studies 
conducted to know the prevalence of the NTM in India were retrospective. The study 
conducted by Chakrabarti et al in Chandigarh, North India had shown that from 8.9% of TB 
suspected patients’ Mycobacteria species were isolated from different specimens(9). The 
detection of the species was done based on tests of Kubica (Biochemical tests used to identify 
the NTM species and based on these tests NTM were classified by Kubica G.P.) (9-10).  The 
isolation of Nontuberculous Mycobacteria (NTM) in Thiruvallur, South India where the BCG 
vaccine trail (Chingleput trial) was done was found to be 8.6%. Here also the isolates of 
species were identified with biochemical tests of Kubica (11). The retrospective study 
conducted by Christian medical college, Vellore, South India had shown that 3.9% of growth 
from different clinical samples had shown NTM (12). The study conducted by Chauhan.M.M 
in rural population of Bangalore had shown that 2.5% of the sputum specimens have yielded 
NTM species (13).    
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The rates of infection and disease by Nontuberculous Mycobacteria (NTM) have been 
reported in the range of 1-15 per 100 000 and 0.1 to 2 per 100 000 in North America (14). 
The study conducted in South Africa among children had shown that 6% crude yield of 
Nontuberculous Mycobacteria from the gastric aspirate and induced sputum (15). The 
prevalence of NTM among Adolescent age group is not known from the previous studies 
conducted. 
 
1.4: Clinical presentation of Pulmonary TB among adolescents: 
The clinical presentation of the TB in adolescent age group is different compared to children 
and adults. Among adolescents the extra pulmonary tuberculosis is more common compared 
to adults.(16-19) The study conducted by Sant ´Anna et al. in Mexico among adolescents 
aged 10 – 18 years had shown that most of the chest radiograph patterns of the pulmonary TB 
were similar to adult type.  Till puberty Pulmonary TB among adolescents is similar to 
children with Ghon complex or primary complex (Ghon focus, lymphangitis and enlarged 
regional lymph nodes) and hematogenous dissemination (Miliary TB). After puberty the 
pathophysiology of pulmonary TB among adolescents is similar to adult type with 
granulomas on histopathology and cavities and cotton wool lesions on chest radiographs (17). 
The study conducted by Weber H.C et al, discussed that, the rise in the occurrence of 
cavitation of lung parenchyma among adolescents with the pulmonary TB starts after 
puberty(20). The study done by Nelson LJ et al, in USA has also shown that there was more 
evidence of pulmonary parenchymal cavitation due to TB on chest radiograph among 
adolescents than adults or children(21).  The review paper by Cruz A.T and Starke J.R in 
Paediatric Respiratory reviews journal have mentioned that fever, cough and productive 
cough are common symptoms among adolescents and night sweats are uncommon. 
Haemoptysis and dyspnoea are rare symptoms among adolescents. Respiratory rales are rare 
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signs among this age group. Other respiratory signs like wheezing, fremitus, dullness to 
percussion and decreased breath sounds are uncommon among the adolescents(19). The study 
conducted by Wong K.S et al in northern Taiwan have found that, among all the clinical 
symptoms of the adolescents with pulmonary TB, cough for more than 4 weeks and 
haemoptysis symptoms were at an increased risk of acid fast bacilli smear positivity(22).  
 
1.5: Why it is important to study TB among adolescents? 
 
 Studies have shown that adolescents are a vulnerable age group having higher chance of 
getting pulmonary TB infection and disease compared to younger children and adults.(16, 20-
21, 23) Studies conducted in United States during 1993 to 2001 had shown that adolescents 
aged 15 to 18 years were more likely to be smear positive. (21) Studies conducted in South 
Africa had shown that the adolescents have the high force of infection (24-25). The high 
force of infection in this age group can be implicated to the increase in the social gathering 
during this age period, which will lead to increase in the exposure to infectious TB disease 
(25). During puberty the pulmonary TB disease is mostly characterised by pulmonary 
parenchymal cavitation and leads to production of sputum with more bacilli which will 
spread to the community (16-17, 19-20). Because most of this age group have wide social 
mixing and gathering in schools and colleges, the diseased person has more chance to infect 
others with TB bacilli.  
 
It is the balance between T cells that is TH1 and TH2 response against TB that causes 
different cytokine secretion and promotes the non-necrotizing and necrotizing response, 
respectively. This T cell response is affected by the ratio of dehydro-epiandrosterone 
(DHEA) and glucocorticoids. The metabolite of vitamin D, 1α 25-dihydroxyvitamin D3 does 
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play a key role in the immunity against the Tuberculosis.(26-28)  The Vitamin D and DHEA 
levels increase progressively from early adolescence. Hence, the adolescent age group is 
special because of physiological changes, that occurs during puberty which plays a role in 
pulmonary TB disease(20). This can explain the higher risk of getting TB disease after recent 
TB infection and re-infection among adolescent age group compared to children and adults 
(19, 22).  
 
 
1.6: Challenges in diagnosing and treatment of the Tuberculosis disease among 
adolescents: 
As the adolescent TB is similar to the TB disease in adults, the diagnostic tests and the 
diagnostic methods used in adults can also be used in adolescent age group. There are no 
special diagnostic guidelines for the diagnosis of tuberculosis among adolescents. The delay 
in the final diagnosis of Tuberculosis disease from the onset of symptoms is a big challenge 
in adolescents. The study conducted in Toronto, Canada has found that the average time from 
the onset of symptoms to diagnosis of Tuberculosis disease was 5.25 months with a median 
of 4 months(18). This delay in diagnosis leads to the delay in the treatment of tuberculosis 
and thus increased infectivity of the diseased person in the community. It is observed that the 
compliance to TB treatment in adolescent age group is difficult because of different social 
issues. It is very important to promote Tuberculosis control programmes in this age group 
because of their unwillingness to the adherence and acceptance of the anti-tubercular 
treatment. (16-18).  
 
1.7: Studies in India: 
There are less data available about patients having symptoms suggestive of TB in India. 
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The studies conducted in the tribal population of Madhya Pradesh among symptomatic 
patients had shown the prevalence of bacillary TB was 387 per 100 000 (29). The tuberculin 
skin test surveys conducted national wide, between 2000 - 03 among children between 1 to 9 
years had shown that the Annual risk of tuberculous infection (ARTI) was 1.5 % (3). This 
was 1.1 % in south zone, which includes the present study area (30).   
The RNTCP status report (TB India 2008) had shown that the annual case detection rate in 
Chittoor was 159 per 100,000 populations in 2007.  The percentage of sputum positive TB 
cases among TB suspects in Chittoor where the study was conducted was 14% in the same 
year (31). The annual case detection rate in India was 130 per 100, 000 population and 
percentage of sputum positive TB cases among TB suspects was 14 in 2007 (31).  
 
1.7.1. Adolescent age group in India: 
Census of India 2001, Population projections for India and states 2001-2026, has projected 
the population aged between 12 to 18 years in Andhra Pradesh state in India is 11.86 millions 
in 2006 which accounts for 15 percentage of the total population in Andhra Pradesh (32). The 
same age group in India was projected to be 170 millions in 2006 which also accounted for 
15 percentage of the total population in India (33).  
 
 
1.8: Diagnosis of Pulmonary Tuberculosis:  
 
Clinical spectrum of Tuberculosis (TB) ranges from latent tuberculosis infection (LTBI) to 
various stages and manifestations of active tuberculosis disease (34-35). In persons having 
suspicion of Tuberculosis disease, detailed medical history and clinical examination along 
with laboratory tests and chest X-ray are done to diagnose the disease (34-35). Tuberculin 
18 
 
skin test (TST) and interferon-γ release assays (IGRA) are the tests among many to diagnose 
the latent TB infection (36-37). 
 
 The interferon-γ release assays are T cell assays. The two IGRA tests currently available are 
T-SPOT.TB test and QuantiFERON-TB Gold test (36, 38). Antibody against Mycobacterium 
tuberculosis based assays, antigens (Lipoarabinomannan detection assay and MPB64 skin 
patch test)  produced by Mycobacterium tuberculosis assays are other recent immune based 
diagnostic tests available for diagnosing the probable active Tuberculosis(36).  Chest X-ray 
and clinical assessment of the person have a vital role in differentiating the LTBI from active 
pulmonary TB disease when TST and IGRAs are used for diagnosis of LTBI. 
 
In countries like India, detection of acid fast bacilli in sputum smear on microscopy is widely 
used diagnostic technique for pulmonary tuberculosis disease. This technique is relatively 
simple, inexpensive, widely applicable and highly specific for Mycobacterium tuberculosis 
(34-35). There are two procedure for acid fast staining, carbolfuchsin procedure and 
Flourochrome procedure. Ziel-Neelsen staining (Z-N staining) and Kinyoun methods are 
used in carbolfuchsin procedure. According to Directly observed treatment short-course 
(DOTS) strategy and Revised National Tuberculosis Control Programme (RNTCP) in India, 
conventional direct microscopy of two consecutive days sputum specimen and one of them 
being a morning sputum specimen is confirmatory diagnostic test for Tuberculosis 
disease.(39) If at least one sample between two sputum specimen is positive for acid fast 
bacilli with Z-N staining then the sample is considered as positive for M.tb and anti-
tuberculosis treatment will be started for that person(39). Studies have shown that sputum 
processing for centrifugation &chemical process and fluorescent microscopy has higher 
sensitivity and comparable specificity compared with conventional direct microscopy (40-
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42). The limitations for using the Fluorescent microscopy and concentrated sputum 
examinations at national level TB control programme in countries like India are higher cost 
of the technique and difficulties in establishing the infrastructure (40-41).  Detection of acid 
fast bacilli in stained smears on microscope may also represent Mycobacterium other than 
tuberculosis NTM so it is not confirmatory gold standard test for M.tb (34-35).  
 
Studies have shown that nucleic acid amplification using Polymerase chain reaction (PCR) 
has a sensitivity of 75-88% and 100% specificity(35). The PCR confirms the diagnosis of the 
sputum smear positive cases. The results of the PCR must be interpreted with the clinical 
evaluation of the patient because the test is positive even in cured and treatment completed 
cases(35). Culture of the mycobacterium on culture media is the confirmatory gold standard 
test for definite diagnosis of Tuberculosis (34-36, 43). The culture provides the isolates for 
identification of species and drug susceptibility testing(43). The culture media available 
currently are Lowenstein-Jensen media (egg based media), Middlebrook media (agar based 
media) and a liquid media(35). BACTEC 460 and BACTEC MGIT 960 (Becton Dickinson, 
USA) are two automated liquid broth culture systems used currently (35, 43). BACTEC 460 
system is radiometric system and TK culture media is a new calorimetric system (36, 43-44). 
The growth in the liquid media is rapid (1-3 weeks) compared to the growth in solid media 
like Lowenstein-Jensen media and agar media (3-8 weeks). Prolonged time for the growth, 
contamination and high cost are limitations of the culture. Mycobacteriophage technique is a 
new rapid, very expensive test for detection of M.tuberculosis (35, 43).    
     
The present study is part of a prospective, observational two year cohort study conducted 
among school/ college going adolescents, 12-18 years in Palamaner taluk with no 
experimental treatment and with the primary objective of estimating the incidence of 
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pulmonary tuberculosis disease. In this cohort study the participants were selected from the 
schools. A stratified randomisation procedure was chosen to assign the selected schools to 
either active or passive surveillance methodology.  After informed consent all the eligible 
participants were followed during a 2 year follow-up period to assess signs or symptoms of 
tuberculosis disease according to the type of surveillance i.e. either active or passive. At the 
start of study (Day 0) blood draw for immunological tests for diagnosis of Tuberculosis and 
tuberculin skin test were performed among all participants. Parents and adolescents were 
interviewed with a questionnaire to determine the socio-demographic characteristics of the 
participants and symptoms suggestive of Tuberculosis. The participants in the active follow-
up group were followed up at every third month and asked for any signs or symptoms of 
Pulmonary TB and blood draw was also performed. At 1 year visit to the participants in 
active surveillance, Tuberculin skin test was performed. At the final study visit (Day 720) the 
procedures done at day 0 were repeated among all participants in both active and passive 
surveillance group. During the follow-up or on the day 0 visits or during the final study visit, 
if the participant had any referral criteria for diagnostic ward then they were motivated to 
attend the diagnostic ward (DGW) to test for pulmonary tuberculosis. 
 
2. Rationale:  
 
The data available regarding adolescent TB was very less from the studies conducted globally 
and in India. As discussed above the adolescent age group is vulnerable and has a higher 
chance to get Pulmonary TB infection. The risk of getting TB disease after TB infection is 
high in Adolescent age group compared to adults.(45) This age group is a target group for 
vaccination. Thus we want see the proportion of definite and probable TB disease among the 
adolescent age group.   
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From the study conducted in Chingleput, South India to know the efficacy of BCG vaccine, it 
was suggested that the exposure of the participants  to Nontuberculous Mycobacteria present 
in the environment might develop immunity and thus the efficacy of BCG could not be 
elicited properly(11). Keeping this in mind we wanted to determine the frequency of the 
Nontuberculous Mycobacteria among 12-18 years age adolescents with symptoms suggestive 
of pulmonary TB, positive TST and recent TB contact in South India.  
        
 3. Objectives:  
 
3.1. Primary objective: 
 
• To estimate the proportion of definite TB and probable TB in 12-18 year old 
adolescents having any referral criteria i.e. symptoms suggestive of TB, recent TB 
contact and positive Tuberculin skin test (TST) in Palamaner taluk, Andhra Pradesh, 
south India. 
3.2. Secondary objectives: 
• To estimate the rate of Nontuberculous Mycobacteria (NTM) in the same group. 
 
4. Methods: 
4.1. Study Site: 
The study was conducted in Palamaner taluk of Chittoor District of Andhra Pradesh in India.  
The study area consisted of 397 population units and 384 rural, with an estimated population 
of approximately 272 000.  
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4.2. Study population:  
Adolescents in the age group of 12-18 years attending the diagnostic ward with referral 
criteria. 
 
Palamaner, Chittoor district, Andhra Pradesh, South India 
 
4.3. Study design: 
The data were collected as part of a prospective, cohort study of school going 12 to 18 years 
old adolescents, with the primary objective of estimating the two year incidence of 
tuberculosis conducted during February 2007 to July 2010. The current paper discusses only 
about the diagnostic ward data, which were collected when the participants were referred to 
the diagnostic ward if they had any of the criteria for referral.  
 
Number of subjects: A total of 609 participants in 12-18 years age group, who attended the 
diagnostic ward with any of the criteria for referral. 
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4.4. Eligibility: 
 
4.4.1. Referral Criteria: 
1. Participants having recent history of positive TB contact (contact for more than 8 
hours per week). 
2. Symptoms suggestive of TB (Unexplained cough, unexplained fever, unexplained 
weight loss and unexplained night sweats for more than 2 weeks and Haemoptysis) 
3. If the participant was diagnosed with pulmonary TB by any other physician 
4. Tuberculin skin test (TST) was positive (TST ≥10mm). 
 
4.4.2. Inclusion criteria:  
• Male and female adolescent volunteers 12-18 years of age attending high school or 
junior college in the Palamaner Taluk. 
• Informed consent from parent or guardian and assent from the subjects or consent 
from the subject if he or she is 18 years or older. 
 
4.4.2. Exclusion criteria: 
• Plan for the family to move from the study area in two years following enrolment 
• Unable to attend follow-up session for reading of the tuberculin skin test. 
 
4.5. Assessments:  
 
4.5.1. Questionnaire: 
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 Once the participant comes to the diagnostic ward the date of diagnostic visit and the way of 
referral to diagnostic ward i.e. by whom, the participant was referred to the diagnostic ward 
were noted on the source document from referral form. For self-referral there will be no 
referral form. Information about current symptoms suggestive of Tuberculosis i.e. any recent 
illness, recent weight loss, cough, fever, night sweats and haemoptysis were noted down on 
the questionnaire. The duration of symptoms and history of treatment for those symptoms 
was noted if it was known by the respondent. The respondent might be parent/ guardian or 
the participants themselves. The source of information (respondent) was noted on source 
document. The respondent was also asked about history of current or past tuberculosis 
disease and history of close contact for more than 8 hours per week, with an adult with 
proven tuberculosis. 
 
4.5.2. Clinical evaluation: 
 
 The height and weight of the participants were recorded. Height was measured to the closest 
0.1 cm using a standard measuring tape with the participant standing against a wall in the 
Frankfurt plane while weight was recorded in clothes but without footwear to the nearest 0.1 
kg using a calibrated manual weighing scale (Bhaseen Health Product Pvt. Ltd., Jalandhar, 
India). Blood pressure, temperature, pulse were noted by the physician or research nurse. 
Detailed systemic examination of the participant was done by the physician. Body mass index 
(BMI) for age Z-score, calculated with the Anthroplus software (WHO 2010). Based on the 
BMI for age Z-score participants were classified into Underweight (BMI – Age Z-score less 
than or equal to -2), Over weight (BMI – Age Z-score greater than or equal to 1) and Normal 
(BMI – Age Z-score between -2 to 1; doesn’t includes -2 & 1)  
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A radiograph in posterior anterior view of the chest was taken after the clinical examination 
by a radiology technician. The radiograph was read by an expert radiologist designated for 
the study and graded normal, abnormal but not indicating tuberculosis, or abnormal 
indicating possible tuberculosis. The participant was asked to collect the sputum in a sterile 
container provided by the research laboratory of the project. The participant was told about 
the way of collecting the sputum. If the participant was unable to produce the sputum sample 
naturally then chest physiotherapy was done. Even after chest physiotherapy if he/she were 
unable to naturally produce the sputum, an induced specimen would be obtained. The 
participant was asked to collect the second day early morning sputum specimen in a new 
sterile container. The second day specimen was given to the research field staff by the 
participant. The field staffs were delegated to bring the specimen to the diagnostic ward. The 
consistency of the sputum sample i.e. salivary, mucoid, muco-purulent and blood stained was 
noted. The gender of the participant was not noted in the questionnaire. 
 
4.6. Laboratory Procedure: 
 
The sputum specimens were examined by concentrated AFB smear microscopy and 
processed for culture. The media used for the culture of Mycobacteria were both Lowenstein-
Jensen medium and MGIT medium. If a specimen was culture positive, the species of the 
isolate were confirmed using a GenoType Mycobacterium CM kit and GenoType MTBC kit. 
 
GenoType Mycobacterium CM kit: It is the test based on the DNA strip technology and 
identifies the different Mycobacterial species.  The Interpretation Chart of this kit identifies 
following species with conjugate control band, Universal control band, Genus control band 
and Species specific band: 
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High GC gram positive Bacterium, Mycobacterium species, M.avium ssp, M.chelonae, 
M.abcessus, M.fortuitum-1, M.fortuitum-2, M.gordonae, M.intracellulare, M.scrofulaceum, 
M.interjectum, M.kansasii, M.malmoense, M.marinum, M.ulcerans, M.tuberculosis complex, 
M.peregrinum (M.alvei/ M.septicum), M.xenopi.(46-47)  
 
GenoType MTBC kit: This is also based on DNA strip technology. This kit can identify 
M.africanum, M.bovis BCG, M.bovis ssp bovis, M.bovis ssp. caprae, M.microti, and 
M.tuberculosis. This kit is used only after the GenoType Mycobacterium CM kit, identifies 
M.tuberculosis complex (47). 
 
 Conjugate Control: “The line must develop in this zone, documenting the efficiency of a 
conjugate binding and substrate reaction”. (Reference) 
 
Universal Control: “This zone detects, as known all Mycobacteria and members of the group, 
gram positive bacteria with Guanine (G) and Cytosine (C) content. If this zone and conjugate 
control zone stain positive but the remaining band patterns can’t assign to a specific 
Mycobacteria, additional methods have to be applied to identify the respective bacterial 
species”. (Reference) 
 
Genus Control (MTBC specific band): “This zone hybridizes, as known, with amplicons 
generated from all members of Mycobacteria tuberculosis complex”. (Reference)  
 
Reference: Genotype MTBC. Ver1.X Hain Life Sciences. GmbH Nehren, Germany 
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The reference laboratory is Division of Infectious diseases, St. John’s Research institute. The 
participant was asked to collect a minimum of 5 ml of urine. Urine specimens were frozen 
and stored for later analysis by a urinary M.tb antigen detection assay or molecular diagnostic 
assay. Results of urine testing were not used in clinical decision-making. Study participants 
might have blood draw as part of the clinical parameters. All the specimens were sent to the 
laboratory from diagnostic ward in an ice-pack box at the earliest. The results of these 
examinations were communicated to the study participant’s parent/guardian and medical care 
provider. If either sputum specimen was smear or culture positive, the results were also 
reported to the public sector tuberculosis control program (RNTCP-DOTS).  If anti 
tuberculosis treatment was given to the participant, it was recorded in the source documents. 
If any adverse events occurred at the time of diagnostic visit, those were noted and reported 
to the institutional review board and sponsors.  
 
4.7. Data management and analysis:  
All data collected were entered into customized data acquisition software. A 100% check of 
the data forms was done to assess missing data and clarity of data prior to data entry. Double 
data entry was done and disparities reconciled against the data forms. Statistical Package for 
Social Sciences Version 17.0 (SPSS, 17.0, SPSS Inc, Chicago, IL, USA) has been used for 
the analysis of the data. The data collected contains the categorical variables, so the 
proportion, percentage and rates were calculated. The odds ratios and 95% confidence 
intervals were calculated to know the association between the variables. Binary logistic 
regression method was used to adjust the confounders. In binary logistic regression the 
confounding is adjusted for age, gender, cough for more than two weeks, type of cooking fuel 
used by the household, TB exposure, Body mass index for age Z score and recent TST value 
in case of Definite TB and definite & probable TB. The same was adjusted for age, gender, 
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cough for more than two weeks, type of cooking fuel used by the household, TB exposure, 
Body mass index for age Z score, caste to which the participant belongs and recent TST value 
in case of NTMs. 
 
4.8. Ethical considerations, ethical review and approval:  
Written informed assent from the subjects and consent from the parents or guardians was 
obtained at the time of enrolment of the participant before the start of the procedure. The 
study protocol and informed consent forms were reviewed & approved by the Institutional 
Review Board (IRB) of St John’s Medical College, Bangalore and by an Independent Ethics 
Committee (IEC) of the Aeras Global TB Vaccine Foundation, USA. The studies were also 
approved by the Ministry of Health Screening Committee of the Government of India (No. 
5/8/9/52/2006-ECD-I dt. 10.11.2006). 
 
The study was stopped in September 2008 and restarted in November 2008 because of 
change in sponsors. When the study was restarted, re-consent was obtained because of 
change in the protocol.     
 
5. Results: 
 
5.1. Participants: 
 
During the 2 years follow-up of 6643 participants, 609 participants attended the diagnostic 
ward (DGW) for Tuberculosis testing. Out of 609 participants, 336 (55.2%) were referred 
from active follow-up and 273 (44.8%) were from passive follow-up. Among 609 
participants, 3 participants attended the diagnostic ward 3 times and 16 participants attended 
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2 times to the diagnostic ward during the period of 2 years. Among all the multiple visits by a 
single participant, the latest visit to the DGW was taken into the consideration and remaining 
visits were excluded from the analysis.  
 
 
5.2. Description of Participants: 
5.2.1: Demographic details: 
Table 1 and figure 1, show the age and gender distribution of the participants. Among all 
these participants, 310 (50.9%) were males and 299 (49.1%) participants were females.  329 
(54%) of the total participants attended the DGW, belonging to the age group 14 to 15 years 
out of which 170 (56.7%) were females and 159 (51.5%) were male participants, followed by 
16-17 years age group with 157 (25.9%) participants, out of which 86 (27.8%) were male, 
and 71 (24%) were female, participants.  70 (11.5%) participants, of which 44 (14.7%) 
female and 26 (8.4%) male participants belonged to 12-13 years age group and 53 (8.5%) 
participants were in the age group 18-20 years, with 39 male and 14 female. The mean age of 
all the participants at the time of DGW visit is 15.06 years (Standard deviation: SD=1.563). 
The minimum and maximum age of the participants is 12 years and 20 years respectively. 
The male participants were older than female participants.  The mean age of male participants 
was 15.30 (SD=1.62) and for female participants was 14.81 (SD=1.46).   
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Figure 1: Distribution of the participants according to the age and sex. 
5.2.2. Socio-economic characteristics: 
 
Among all the participants majority of the participants’ mothers were illiterate (44.5%), 44 % 
of the participants’ fathers had secondary education or more. 82% of the participants were 
living in houses made of walls with brick and other 18% participants were living in the 
houses constructed with walls made of mud and others. In 84% of the participants’ wood was 
the household cooking fuel.  
 
31 
 
6643 participants 3439 M / 
3204 F
1342  Participants 
739 M / 603 F 
Referral Criteria +
278 participants 
159 M / 119 F 
withdrawn
1064 participants 
581 M / 483 F
609 participants 
screened for TB
310 M / 299 F
455  (43%) not 
screened for TB
7 M.tb culture Positive
1 M / 6 F
NTM positive 116 
75 M / 41 F
Probable TB – 3
2 M / 1 F
Baseline TST- 387,
TST conversion – 119
Only symptoms – 46
H/O TB contact – 38
Other combinations - 19
Sputum collected –
596
Culture for M.tb/ 
NTM was invalid - 6
Culture for M.tb/ NTM 
was Positive - 123
Culture for M.tb/ NTM was 
negative - 467
226 M/ 241 F
 
 
Figure 2: Study Profile 
DGW: Diagnostic ward, MTB: Mycobacterium tuberculosis, NTM: Nontuberculous 
Mycobacteria. TST: Tuberculin skin test, H/O TB: History of TB contact, BTST: Baseline 
TST, AFB: Acid fast bacilli, Probable TB – Chest X-ray was abnormal for TB 
 
 
Table 1:  Characteristics of participants admitted into the Diagnostic ward for diagnostic 
evaluation of tuberculosis 
 
Variables  1 Visit  >= 2 Visits 
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(n=609) (n=22) 
Age category   
12-13 years 
14 – 15 years 
16 – 17 years 
18 – 20 years 
 
70 (11.5) 
329 (54.0) 
157 (25.8) 
53 (8.7) 
 
0 
8 (36.36) 
8 (36.36) 
6 (27.27) 
Gender 
                               Male 
Female 
 
310 (50.9) 
299 (49.1) 
 
14 (63.6) 
8 (36.4) 
Socio-economic characteristics 
Education of Mother 
Illiterate 
Primary 
Secondary or more 
 
270 (44.5) 
192 (31.6) 
145 (23.9) 
 
11 (50.0) 
5 (22.7) 
6 (27.3) 
Education of Father 
Illiterate 
Primary 
Secondary or more 
 
157 (26.0) 
184 (30.4) 
264 (43.60 
 
8 (38.1) 
2 (9.5) 
11 (52.4) 
Type of wall of house 
Brick 
Others 
 
499 (81.9) 
110 (18.1) 
 
19 (86.4) 
3 (13.6) 
Cooking fuel used                          
                                         Wood 
Others 
 
511 (83.9) 
98 (16.1) 
 
17 (77.3) 
5 (22.7) 
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Symptoms 
1
 
Cough                                        
                                             Yes 
No 
 
76 (12.5) 
533 (87.5) 
 
9 (40.9) 
13 (59.1) 
Weight Loss    
                                             Yes 
                                               No                                   
 
29 (4.8) 
579 (95.1)
 
3 (13.6) 
19 (86.4) 
Fever                                                                                                   
                                             Yes 
                                              No 
 
51 (8.4) 
558 (91.6) 
 
3 (13.6) 
19 (86.4) 
Haemoptysis 
                                             Yes 
                                              No 
 
6 (1.0) 
603 (99.0) 
 
0 (0) 
22 (100.0) 
Night sweats 
                                             Yes  
                                              No 
 
11 (1.8) 
597 (98.0) 
 
0 (.0) 
22 (100.0) 
Cough more than 2 weeks 
Yes 
No 
 
46 (7.6) 
563 (92.3) 
 
6 (27.3) 
16 (72.7) 
Fever more than 2 weeks 
Yes 
No 
 
25 (4.1) 
583 (95.7) 
 
1 (4.5) 
21 (95.5) 
Haemoptysis more than 2 
weeks 
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Yes 
No 
2 (0.3) 
607 (99.7) 
0 (.0) 
22 (100.0) 
Night sweats more than 2 weeks 
Yes 
No 
 
7 (1.1) 
601 (98.7) 
 
0 (.0) 
22 (100.0) 
Participant diagnosed TB prior 
to diagnostic visit 
                                             Yes 
                                              No  
 
 
2 (0.3) 
607 (99.7) 
 
 
0 (.0) 
22 (100.0) 
Contact 
2
 
                                             Yes 
                                              No 
 
67 (11.0) 
538 (88.3) 
 
6 (27.3) 
16 (72.7) 
Recent TST value 
3 
                  < 10 mm 
≥10 mm 
 
165 (27.1) 
443 (72.9) 
 
8 (36.4) 
14 (63.6) 
BAZ 
4
 
Underweight  
Normal  
 Overweight or Obese  
 
269 (45.3) 
312 (52.5) 
13 (2.2) 
 
10 (47.6) 
10 (47.6) 
1 (4.8) 
 
1. The symptoms were recorded at the time of diagnostic visit in diagnostic ward 
(DGW). They might not be the referral criteria. 
2. The contact with a positive TB case for more than 8 hours a week. 
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3. Recent Tuberculin skin test (TST) value is the latest test value corresponding to the 
diagnostic ward (DGW) visit. For one participant TST was administered but was not 
available for TST reading. 
4. BAZ: Body mass index (BMI) for age Z-score. Calculated with the Anthroplus 
software (WHO 2010). Under weight – Less than or equal to -2; Over weight – 
Greater than or equal to 1; Normal – Between -2 to 1 (Doesn’t includes -2 & 1) 
 
Missing Data:  Education of Mother – 1, Education of Father – 3, Weight loss – 1, Night 
sweats – 1, Contact – 14, Recent TST – 1 and BAZ – 15 
 
 
5.2.3. Information on exposure according to referral criteria available from Diagnostic ward 
questionnaire and field questionnaire: 
 
Of the 609 participants attended the DGW, majority (64.6%) of them were referred because 
of Baseline TST (Day 0 TST) was equal to or greater than 10 mm, 119 (19.5%) had only TST 
conversion at the time of follow-up, 46 participants (7.6%) had only symptoms suggestive of 
tuberculosis, 38 (6.2%) had only history of household contact or class room contact with an 
individual with TB, 2 (0.33%) participants had both symptoms and history of contact as 
referral criteria, 9 (1.5%) participants had symptoms and TST ≥ 10 mm at baseline, 1 (0.16%) 
participant had symptoms and TST conversion and 2 (0.33%) participants had history of TB 
contact and TST ≥ 10 mm as referral criteria. Table 2 gives the information about the 
participants’ referral criteria to the DGW based on the information available from referral 
forms and field data. 
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Table 2: Referral criteria for the participants: 
 
Referral criteria Number of Participants 
 n = 609 (%) 
Only Symptoms suggestive of TB 
1
 46 (7.55) 
Only History of household contact or class 
room contact with an individual with TB 
38 (6.24) 
Only Tuberculin skin test more than or 
equal to 10mm at baseline 
387 (63.55) 
Only Tuberculin skin test conversion at the 
time of follow-up 
119 (19.54) 
Symptoms and history of TB contact 2 (0.33) 
Symptoms and TST ≥ 10 mm 9 (1.48) 
Symptoms and TST conversion during 
follow-up 
1 (.16) 
History of TB contact and TST ≥ 10 mm at 
Baseline 
2 (0.33) 
Self Referral to the DGW 
2
 5 (0.82) 
 
1. Symptoms suggestive of TB include: Unexplained cough, unexplained fever, 
unexplained weight loss and unexplained night sweats for more than 2 weeks and 
Haemoptysis 
2.  Among the 5 self referral participants 3 had symptoms suggestive of TB and 2 
participants had TB exposure. 
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 The tuberculin skin test results (TST), corresponding to the diagnostic ward visit were 
imported from the data collected from field questionnaire. The recent TST result using a cut-
off value of 10 mm at the time of their diagnostic ward (DGW) visit shows that 443 (72.9%) 
participants were positive for TST result (greater than or equal to 10 mm) and 165 (27.1%) 
participants were negative for TST (less than 10 mm). Table 3 shows the frequency of 
participants according to their recent TST result stratified according to the age and gender.  
 
 
Table 3: Frequency of participants according to the tuberculin skin test results using a cut-off 
value of ≥ 10 mm. 
 
  TST < 10 mm TST ≥ 10 mm Total
1
 
Sex 
Male 
74 
44.8% 
235 
53.0% 
309 
50.8% 
Female 
91 
55.2% 
208 
47.0% 
299 
49.2% 
Total 
165 
100.0% 
443 
100.0% 
608 
100.0% 
Age group 
12- 13 years age 
20 
12.1% 
50 
11.3% 
70 
11.5% 
14-15 years age 
85 
51.5% 
243 
54.9% 
328 
53.9% 
16- 17 years age 42 115 157 
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25.5% 26.0% 25.8% 
18-20 years age 
18 
10.9% 
35 
7.9% 
53 
8.7% 
Total 
165 
100.0% 
443 
100.0% 
608 
100.0% 
 
 
 
Table 1 describes information regarding the demographic details of the participants, 
symptoms, Body mass index for age – Z score (BAZ), BCG (Bacillus calmette guarine) scar 
status of the participant, history of contact and tubeculin skin test (TST) which was recent to 
the DGW visit.  
 
 
5.2.4. Anthropometric details: 
 
Among all the participants 52.5% of the participants’ Body mass index for age Z (BAZ) score 
was normal (BAZ was between -2 to 1) and 45.3% of the participants were underweight 
(Less than or equal to – 2). For 15 participants height and weight were missing so BAZ was 
not calculated.  
 
5.2.5. Clinical details at the time of DGW visit: 
 
Out of the 609 participants who attended the diagnostic ward, 29 (4.8 %) had experienced 
recent loss of weight. 76 participants had cough, of these 46 (7.6%) had cough for more than 
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or equal to 2 weeks. There were 51 (8.4%) participants who had fever at the time of DGW 
visit and of these, 25 participants had fever equal to or greater than 2 weeks. 6 (1.0 %) 
participants had haemoptysis and 2 of them had the symptoms for more than 2 weeks. 11 (2.0 
%) participants had night sweats at the time of DGW visit and among these participants, 7 
(1.1%) participants had the symptom for more than 2 weeks. Two (0.3%) participants were 
diagnosed as pulmonary TB outside the DGW and prior to their DGW visit, and both of them 
were on the treatment for tuberculosis.  Among all these participants, 67 (11.0 %) of them 
had experienced a significant exposure to an individual on TB treatment. For 443 (73%) 
participants, the recent TST corresponding to the DGW visit was positive (equal to or greater 
than 10mm). 
 
5.2.6. Responders (Informants): 
 
The source of information (respondent) for majority of the participants (65%) was adolescent 
himself/ herself. It was the mother for 12% of the participants, 15% had father as informants, 
3% had grand -parents. For 5% participants it was others. 
 
5.2.7. Diagnostic test results of participants and other details: 
 
All the 609 participants were screened with chest radio graph P-A view for TB disease. For 
13 participants neither day 1 or day 2 sputum samples were collected. Of remaining 596 
participants 4 participants had only the day 1 sputum sample collected. If only one sample 
was available, depending on the result this sputum sample, the participant was considered as 
positive or negative for M.tb or NTM. For 4 participants’ sputum samples were contaminated 
during the culture in either one of the day sample, so the other sample result was considered 
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for the output (M.tb result/ NTM result). The DNA strip test (GenoType Mycobacterium CM 
kit and GenoType MTBC kit) results were invalid for 6 participants, so the culture of M.tb/ 
NTM results for those were considered as missing data.  So the result for M.tb or NTM was 
available for 590 participants. 
 
5.2.7.1. Chest X-ray results:  
 
The chest radiograph was abnormal for TB in 7 (1.15%) participants and in 9 (1.5%) 
participants it was abnormal but not TB. Out of 7 participants, who had chest x-ray abnormal 
for TB, 4 participants were positive for M.tb on culture of the sputum sample. Remaining 3 
participants were negative for the culture. Of the two participants who were diagnosed as 
Pulmonary TB prior to the DGW visit, chest radiograph was abnormal for TB in one 
participant and the other’s chest radiograph was abnormal, not TB.  
 
5.2.7.2. Sputum sample culture and acid fast bacilli smear results:   
 
Table 4 gives the number of participants with sputum sample positive for smear for AFB and 
positive for M.tb culture. Of 590 participants with sputum culture results available, 7 (1.14 
%) participants’ sputum samples were culture positive for Mycobacterium tuberculosis. Out 
of these 7 participants, 4 participants’ sputum samples’ were positive for Acid fast bacilli 
(AFB) smear on both days. Day 1 and day 2 sputum samples were positive for culture of M.tb 
in 5 participants and in 2 participants only day 1 was positive for M.tb culture. In 1 
participant only day 2 sputum sample was positive for AFB smear and is negative for culture 
of M.tb and the culture is positive for Mycobacterium scrofulaceum. The same participant 
didn’t have any symptoms at the time referral and the recent TST was 20 millimetres 
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Table 4: M.tb culture and sputum smear results: 
 
 
 
Sputum positive for 
culture of M.tb 
1
 
Sputum negative for 
culture of M.tb 
1
 
Total 
Sputum smear 
positive for AFB 
2
 
4 
(57.1%) 
1 
(0.2%) 
5 
.8% 
Sputum smear 
negative for AFB 
2
 
3 
(42.9%) 
582 
(99.8)% 
585 
100% 
Total 
7 
(100%) 
583 
98.8% 
590 
100.0% 
1. The sputum positive either in day 1 or day 2 or both days sputum 
2. The sputum positive for AFB smear either in day 1 or day 2 or both 
 
 
Table 5 gives the information regarding participants with sputum samples’ culture positive 
for NTM with sputum samples positive for AFB smear. Among all participants who were 
screened for sputum culture, 116 (19.05%) participants were positive for NTM species on 
culture in either day 1 or day 2 sputum or both day 1 and day 2. Among 116 participants who 
were positive for NTM on culture of the sputum sample, 1 participant was positive for AFB 
smear. M.scrofulaceum was isolated from this participants’ sputum sample. 
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Table 5: Participants with sputum positive for culture of MOTT with sputum positive for 
AFB smear. 
 
 
 
Sputum positive for 
culture of NTM  
1
 
Sputum negative for 
culture of NTM  
1
 
Total 
Sputum smear 
positive for AFB 
2
 
1 
(0.9%) 
0 
.0% 
1 
0.2% 
Sputum smear 
negative for AFB 
2
 
115 
(99.14%) 
467 
100.0% 
582 
99.8% 
Total 
116 
(100.0%) 
467 
100.0% 
583 
100.0% 
1. The sputum positive either in day 1 or day 2 or both days sputum 
2. The sputum positive for AFB smear either in day 1 or day 2 or both 
 
5.2.8: Participants with sputum samples positive for culture of Nontuberculous Mycobacteria 
(NTM) details: 
 
Out of 116 participants positive for NTM, 59 day 1 sputum samples were positive for NTM 
and 68 day 2 sputum samples were positive for NTM. Both day 1 and day 2 sputum samples 
were positive for culture of NTM in 11 participants, where as in 105 participants’ sputum 
samples were positive for culture of NTM only either in day 1 or day 2. (Table 6) A total of 
127 samples have yielded NTM species from 116 participants. Sputum samples from 6 
participants have yielded two different species of NTMs from the day 1 and day 2 sputum 
samples. From 33 participants a total of 36 sputum samples have shown the growth of 
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Mycobacterium species, for which the particular species of the Mycobacteria was not 
identified by the GenoType Mycobacterium CM kit. A total of 19 sputum samples have 
yielded NTM growth but GenoType Mycobacterium CM kit doesn’t show the species for 
which it belongs, it is then considered as NTM indeterminate. Among all the species of NTM 
found on culture, M.fortuitum, M.intracellulare, M.scrofulaceum have dominated other 
species i.e. M.chelonei, M.gordonae, M.interjectum, M.kansasii on isolation of the species 
from sputum samples. Table 8 gives the frequency of NTM species. M.fortuitum accounts for 
24% of the total NTM positive participants followed by M.intracellulare in 12.6% of 
participants and M.scrofulaceum in 11% of the participants. In 4 participants M.kansasii and 
in 3 participants M.gordonae species were isolated. M.interjectum was isolated from 2 
participants and M.chelonei was isolated in 2 participants. 
 
Table 6: Frequency of NTM species 
 
 
 NTM species 
Isolation of NTM by sputum 
samples (%) 
Isolation rates by participants 
Number (%) 
€
 
M. fortitium 31 (24.41) 31 (25.41) 
M. intracellulare 16 (12.60) 16 (13.11) 
M. scrofulaceum 14 (11.02) 13 (10.66) 
M. kansasii 04 (03.15) 04 (03.28) 
M. gordonae 03 (02.36) 03 (02.46) 
M. interjectum 02 (01.57) 02 (01.64) 
M. chelonae 02 (01.57) 02 (01.64) 
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Indeterminate 
1
 19 (14.96) 18 (14.75) 
Mycobacterium species 
2
  36 (28.35) 33 (27.05) 
Total NTMS 127 (100.0) 
3
 122 (100) 
4
 
MTBC/ NTM Invalid 
5
 6 6 
 
€: Participant was counted twice if the two sputum samples yielded two different species. So 
the number is more than 116 participants. 
1. The HAIN kit shows bands for conjugate control and universal control. There was no 
genus control band. The species of NTM was not mentioned. 
2. The kit shows all the three bands (Conjugate control, universal control and genus 
control). The kit specifies the specimen as Mycobacterium species. The specimen can 
be looked for further speciation of the bacteria. 
3. The number includes both day 1 and day 2 sputum samples isolates, if they are 
positive in both samples. 
4.  The number includes both day 1 and day 2 sputum samples isolates, only if there are 
two different isolates in those two samples of a single participant. 
5. The HAIN Genotype was invalid either for MTBC or NTM 
 MTBC – Mycobacterium tuberculosis complex, NTM – Mycobacterium other than 
tuberculosis 
 
Conjugate Control: “The line must develop in this zone, documenting the efficiency of a 
conjugate binding and substrate reaction”. (Reference) 
 
Universal Control: “This zone detects, as known all Mycobacteria and members of the 
group, gram positive bacteria with Guanine (G) and Cytosine (C) content. If this zone and 
45 
 
conjugate control zone stain positive but the remaining band patterns can’t assigned to a 
specific Mycobacteria, additional methods have to be applied to identify the respective 
bacterial species”. (Reference) 
 
Genus Control (MTBC specific band): “This zone hybridizes, as known, with amplicons 
generated from all members of Mycobacteria tuberculosis complex”. (Reference)  
 
Reference: Genotype MTBC. Ver1.X Hain Life Sciences. GmbH Nehren, Germany 
 
5.3. Outcome: 
The participants with sputum sample positive for culture of M.tb either in day 1 or day 2 or 
both were considered as definite TB. The participant whose chest X-ray showed the changes 
positive for pulmonary tuberculosis and the sputum sample of the participant was negative 
for culture of M.tb were considered as positive for Probable TB.  Figure 1 shows the profile 
of the study. A total number of 7 (1.15 %) participants were diagnosed as definite TB, 3 (0.50 
%) participants were diagnosed as probable TB. The proportion of 19.05% participants had 
NTM positive sputum samples. Table 7 denotes the characteristics and details of all the 10 
participants who were diagnosed as Definite TB or Probable TB. Of the 7 participants who 
were diagnosed as having definite TB participants, 6 were female. Of those 7 definite TB, 3 
participants didn’t have any symptoms at the time of DGW visit. 
 
Table 7: Characteristics of the participants with culture positive for M.tb and Chest X-ray 
abnormal for TB (Definite TB and Probable TB) 
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SI. 
No  
Participant 
ID 
visit Gender Age BAZ 
3
 
Smear 
result 
Culture 
for M.tb 
Symptoms1  Contact Chest 
x-ray 
TST 
values 
QFT 
Value
2
 
1 12104 3 Male 17 N Positive Positive Yes Yes Abnorm
al TB 
16 + Ve 
2 20116 1 Female 17 U.W Positive Positive Yes No Abnorm
al TB 
15 NA 
3 23061 1 Female 17 N Negative Positive No No Normal 25 + Ve 
4 42107 1 Female 12 U.W Positive Positive Yes No Abnorm
al TB 
7 NA 
5 52301 1 Female 15 U.W Negative Positive No No Normal 17 + Ve 
6 72601 1 Female 15 U.W Positive Positive Yes No Abnorm
al TB 
5  NA 
7 83013 1 Female 15 U.W Negative Positive No No Normal 23  NA 
Probable TB 
8 11001 1 Female 15 N Negative Negative Yes No Abnorm
al for 
TB 
4 NA 
9 41630 1 Male 16 N Negative Negative No Yes Abnorm
al for 
TB 
23 NA 
10 77503 1 Male 14 N Negative Negative No No Abnorm
al for 
TB 
20 NA 
Definite in the latest visit and Probable in 2
nd
 Visit 
11 12104 2 Male 16 N Negative Negative Yes No Abnorm
al for 
TB 
10 + Ve 
 
1: Presence of at least one Symptom suggestive of TB at the time of DGW visit. 
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2: QFT: QuatiFERON; NA = Not available (QFT was not done for those participants) 
3: BAZ: Body mass index (BMI) for Age Z-score. Calculated with the help of Anthroplus 
software - 2007 (WHO). U.W = under weight – Less than or equal to -2; N = Normal – 
Between -2 to 1 (Doesn’t includes -2 & 1); Over weight – Greater than or equal to 1;  
 
 
5.4. Association of outcome results with other variables (Characteristics of 
Participants): 
 
5.4.1: Unadjusted estimates:  
Table 8 gives the association between M.tb positive result on culture and symptoms of 
participants at the time of DGW visit, gender, socio economic status indicators, body mass 
index for age z-score (BAZ), chest x-ray result and corresponding TST result. The 
participants who were having history of recent loss of weight at the time of DGW visit had 18 
times more chance of sputum being positive for M.tb on culture, compared to who were not 
having history of recent weight loss (O.R = 18.26; 95% C.I = 3.86 – 86.38). Participants 
having cough equal to or greater than 2 weeks were, 19 times more likely to become positive 
for M.tb growth of sputum sample compared to participants without having cough equal to or 
greater than 2 weeks (O.R = 18.60; 95% C.I = 4.02 – 86.05). The participants with fever for 
more than or equal to 2 weeks at the time of DGW visit, were having 11 times more chance 
to be diagnosed as Definite TB (Sputum positive for culture of M.tb) and the odds ratio was 
11.26 (95% C.I = 2.06 – 61.60). The association of night sweat for more than 2 weeks at 
DGW visit found significant and the association is weak with odds ratio of 16.02 (95% C.I = 
1.67 – 154.31). There were no participants diagnosed as Definite TB, with presence of 
haemoptysis for more than or equal to 2 weeks at the time of DGW visit. The participants 
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who had chest x-ray changes for pulmonary tuberculosis had 258 times more chance to 
become sputum specimen positive for culture of  M.tb (O.R = 258; 95% C.I = 39.40 – 
1686.46). There was no significant association found with other variable like Socio economic 
status indicators, BAZ score, TB exposure and corresponding TST result to sputum sample 
positivity for culture of M.tb.  
 
Table 8: Association of symptoms, age, gender, socio-economic status and other variables 
with culture results for M.tb 
 
Variables  M.tb 
positive 
(n=7) 
1
 
M.tb 
negative 
(n=583) 
2
 
Unadjusted 
Odds ratio 
95% C.I. 
Adjusted Odds ratio 
95% C.I. 
Age category   
12-13 years 
14 – 15 years 
16 – 17 years
®
 
18 – 20 years 
 
1 (14.3) 
3 (42.9) 
3 (42.9) 
0 (0.0) 
 
 
67 (11.5) 
310 (53.2) 
154 (26.4) 
52 (8.9) 
 
 
0.77 (0.03 - 8.47) 
0.50 (0.08 - 3.12) 
--- 
 
 
0.83 (0.07 – 10.37) 
0.29 (0.02 – 4.46) 
--- 
Gender 
                         Male 
Female 
1 (14.3) 
6 (85.7) 
 
 
301 (51.6) 
282 (48.4) 
 
 
0.16 (0.02-1.31) 
 
 
0.06 (0.005 – 0.75) 
Socio-economic characteristics  
Education of Mother 
Illiterate 
 
2 (28.6) 
 
258 (44.3) 
 
0.27 (0.03-1.72) 
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Primary 
Secondary or more
®
 
1 (14.3) 
4 (57.1) 
186 (32.0) 
138 (23.7) 
0.19 (0.02-1.78) 
Education of Father 
Illiterate 
Primary 
   Secondary or more
®
 
 
0 (0.0) 
1 (14.3) 
6 (85.7) 
 
151 (26.0) 
176 (30.3) 
253 (43.6) 
 
 
0.24 (0.03-2.02) 
 
Type of wall of house 
         Brick 
Others 
 
7 (100.0) 
0 (0.0) 
 
477 (81.8) 
106 (18.2) 
  
Cooking fuel used                            
Wood 
Others 
 
4 (57.1) 
3 (42.9) 
 
492 (84.4) 
91 (15.6) 
 
0.25 (0.05-1.12) 
 
0.38 (0.05 – 3.22) 
Caste 
Dalit 
Others 
 
3 (42.9) 
4 (57.1) 
 
102 (17.5) 
481 (82.5) 
 
3.54 (0.78 – 16.04) 
 
Symptoms 
3
  
Weight Loss                                                
Yes 
                  No                          
3 (42.9) 
4 (57.1)
 
23 (3.9) 
560 (96.1) 
 
18.26 (3.86 – 86.38) 
 
Cough more than 2 
weeks 
Yes 
No 
 
 
4 (57.1) 
3 (42.3) 
 
 
39 (6.7) 
544 (93.3) 
 
 
18.60 (4.02 – 86.05) 
 
 
57.59 (6.06 – 
547.64) 
Fever more than 2 
 
   
50 
 
weeks 
Yes 
No 
 
2 (28.6) 
5 (71.4) 
 
20 (3.4) 
563 (96.6) 
 
11.26 (2.06 – 61.60) 
Haemoptysis more than 
2 weeks 
Yes 
No 
 
 
0 (.0) 
7 (100.0) 
 
 
2 (0.3) 
581 (99.7) 
 
 
1.012 (1.003 – 1.02) 
 
Night sweats more than 
2 weeks 
Yes 
No 
 
 
1 (14.3) 
6 (85.7) 
 
 
6 (1.0) 
578 (99.0) 
 
 
16.02 (1.67 – 
154.31) 
 
Contact  
4
                                           
Yes 
                              No 
1 (14.3) 
6 (85.7) 
 
63 (10.8) 
521 (89.2) 
 
1.38 (0.16 – 11.61) 
 
3.33 (0.29 – 38.42) 
Recent TST value 
5
 
 <10 
≥10 
 
2 (28.6) 
5 (71.4) 
 
163 (28.0) 
419 (72.0) 
 
1.03 (0.20 - 5.35) 
 
0.32 (0.04 – 2.79) 
BAZ 
6
 
Underweight  
Overweight or Obese 
Normal
®
 
 
5 (71.4) 
0 (0.0) 
2  (28.6) 
 
254 (44.6) 
13 (2.3) 
302 (53.1) 
 
2.97 (0.51-22.29) 
 
6.01 (0.87 – 41.31) 
X ray 
Abnormal Tb 
Normal 
 
4 (57.1) 
3(42.9) 
 
3 (0.5) 
580 (99.5) 
 
258 (39.40-1686.46) 
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BCG scar status 
Yes 
No 
 
1 (14.3) 
6 (85.7) 
 
369 (63.3) 
214 (36.7) 
 
0.097 (0.012 – 
0.808) 
 
 
®: Reference variable 
1. The number denotes the number of definite TB; the participants’ sputum samples 
were positive for culture of Mycobacterium tuberculosis (M.tb) either in day 1 or day 
2 or both sputum samples 
2. The participants’ sputum sample was negative for culture of Mycobacterium 
tuberculosis (M.tb) in both sputum samples. If there was only one sputum sample 
available and negative for M.tb, it is also considered as negative for M.tb. For 13 
participants sputum samples were not collected as per old protocol. For 5 participants 
the HAIN Genotype was invalid for M.tb. 
3. The symptoms were recorded at the time of diagnostic visit in diagnostic ward 
(DGW). They might not be the referral criteria. 
4. The contact with a positive TB case for more than 8 hours a week. 
5. Recent Tuberculin skin test (TST) value is the latest test value corresponding to the 
diagnostic ward (DGW) visit. 
6. BAZ: Body mass index (BMI) for age Z-score. Calculated with the help of WHO 
provided software. Under weight – Less than or equal to -2; Over weight – Greater 
than or equal to 1; Normal – Between -2 to 1 (Doesn’t includes -2 & 1) 
 
Missing Data:  Education of Mother – 1, Education of Father – 3, Participants diagnosed 
as TB prior to diagnostic ward visit – 1, recent tuberculin skin test (TST) value - 1 and 
BAZ – 15 
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Table 9 gives the information regarding the association between being positive for Definite 
TB or Probable TB and not TB with symptoms of participants at the time of DGW visit, 
gender, Socio economic status indicators, Body mass index for age z-score (BAZ) and 
corresponding TST result. The univariate analysis done among participants with definite TB 
or probable TB had shown that, the participants with history of recent loss of weight at the 
time DGW visit had 17 times more chance to be diagnosed as definite TB or probable TB. 
Presence of cough for more than or equal to 2 weeks among participants at the time of DGW 
visit had 9 times more likely to be diagnosed as either definite TB or probable TB with an 
odds of 9.25 (95% C.I = 2.51 – 34.15). The participants with history of fever for more than or 
equal to 2 weeks at the time of DGW visit had 7 times more chance to be diagnosed as either 
definite TB or probable TB, with an odds of 7.00 (95% C.I = 1.40 – 35.1). The presence of 
night sweats for more than 2 weeks at the time of DGW visit were found significant but the 
lower limit of the 95% confidence interval was near 1 with odds ratio of 10.6 (95% C.I = 1.16 
– 97.58). The significant association of fever and night sweats were weak because of quite 
less number of the probable TB or definite TB among symptomatic. There was no probable 
TB or definite TB participants with history of haemoptysis for more than 2 weeks. The 
association with other variables including age, gender, socio economic status indicators, night 
sweats, history significant exposure to an individual on TB treatment and TST results on a 
cut-off value of 10 mm (latest TST which was corresponding to the DGW visit) and BAZ 
score found insignificant. 
 
Table 9: Association of symptoms, age, gender, socio-economic status and other variables 
with Definite or Probable TB. 
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Variables  Definite/ 
Probable 
TB 
(n=10) 
1
 
Not TB 
 
 
(n=580) 
2
 
Unadjusted 
Odds ratio 
95% C.I. 
Adjusted Odds ratio 
(95% C.I.) 
Age category   
12-13 years 
14 – 15 years 
16 – 17 years
®
 
18 – 20 years 
1 (10.0) 
5 (50.0) 
4 (40.0) 
0 (0.0) 
 
67 (11.6) 
308 (53.1) 
153 (26.4) 
52 (9.0) 
 
0.57 (0.02 - 5.60) 
0.62 (0.14 - 2.80) 
----- 
 
0.51 (0.05 – 4.91) 
0.30 (0.03 – 3.34) 
----- 
Gender 
                         Male 
Female 
3 (30.0) 
7 (70.0) 
 
 
299 (51.6) 
281 (48.4) 
 
 
0.40 (0.10 - 1.57) 
 
 
0.27 (0.06 – 1.21) 
Socio-economic characteristics  
Education of Mother 
Illiterate 
Primary 
Secondary or more
®
 
 
5 (50.0) 
1 (10.0) 
4 (40.0) 
 
255 (44.0) 
186 (32.1) 
138 (23.8) 
 
0.68 (0.15 - 3.05) 
0.19 (0.01 -1.78) 
 
Education of Father 
Illiterate 
Primary 
  Secondary or more
®
 
 
0 (0.0) 
3 (30.0) 
7 (70.0) 
 
151 (26.2) 
174 (30.2) 
252 (43.7) 
 
 
0.62 (0.13 - 2.70) 
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Type of wall of house 
         Brick 
Others 
 
9 (90.0) 
1 (10.0) 
 
475 (81.9) 
105 (18.1) 
 
1.99 (0.25 – 15.87) 
 
Cooking fuel used                            
Wood 
Others 
7 (70.0) 
3 (30.0) 
 
489 (84.3) 
91 (15.7) 
 
0.43 (0.11 - 1.71) 
 
0.61 (0.12 – 3.1) 
Caste 
Dalit 
Others 
 
4 (40.0) 
6 (60.0) 
 
101 (17.4) 
479 (82.6) 
 
3.16 (0.88 – 11.41) 
 
     
Symptoms 
3
  
Weight Loss                                                
Yes 
                  No                                   
4 (40.0) 
 6 (60.0)
22 (3.8) 
558 (96.2) 
 
16.90 (4.45 – 64.25) 
 
Cough more than 2 
weeks 
Yes 
No 
 
 
4 (40.0) 
6 (60.0) 
 
 
39 (6.7) 
541 (93.3) 
 
 
9.25 (2.51 – 34.15) 
 
 
18.62 (3.66 – 94.77) 
Fever more than 2 
weeks 
Yes 
No 
 
 
2 (20.0) 
8 (80.0) 
 
 
20 (3.4) 
560 (96.6) 
 
 
7.00 (1.4 – 35.1) 
 
Haemoptysis more 
than 2 weeks 
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Yes 
No 
0 (.0) 
10 (100) 
2 (0.3) 
578 (99.7) 
1.02 (1.01 – 1.03) 
Night sweats more 
than 2 weeks 
Yes 
No 
 
 
1 (10.0) 
9 (90.0) 
 
 
6 (1.0) 
574 (99.0) 
 
 
10.63 (1.16 – 97.58) 
 
Contact  
4
                                           
Yes 
                              No 
2 (20.0) 
8 (80.0) 
 
62 (10.7) 
518 (89.3) 
 
2.09 (0.43 – 10.06) 
 
3.07 (0.55 – 17.13)  
Recent TST value 
5
 
 <10 
≥10 
 
3 (30.0) 
7 (70.0) 
 
162 (28.0) 
417 (72.0) 
 
1.10 (0.28 – 4.31) 
 
0.48 (0.10 – 2.35) 
BAZ 
6
 
Underweight  
Overweight or Obese 
Normal
®
 
 
5 (50.0) 
0 (0.0) 
5  (50.0) 
 
254 (44.9) 
13 (2.3) 
299 (52.8) 
 
1.18 (0.29 – 4.74) 
------ 
 
1.62 (0.42 – 6.22) 
------ 
 
BCG scar status 
Yes 
No 
 
 
3 (30.0) 
7 (70.0) 
 
 
367 (63.3) 
213 (36.7) 
 
 
0.25 (0.064 – 0.97) 
 
 
®: Reference variable 
1. The number denotes the number of definite TB; the participants’ sputum samples 
were positive for culture of Mycobacterium tuberculosis (M.tb) either in day 1 or day 
2 or both sputum samples 
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2. The participants’ sputum sample was negative for culture of Mycobacterium 
tuberculosis (M.tb) in both sputum samples. If there was only one sputum sample 
available and negative for M.tb, it is also considered as negative for M.tb. For 13 
participants sputum samples were not collected as per old protocol. For 5 participants 
the HAIN Genotype was invalid for M.tb. 
3. The symptoms were recorded at the time of diagnostic visit in diagnostic ward 
(DGW). They might not be the referral criteria. 
4. The contact with a positive TB case for more than 8 hours a week. 
5. Recent Tuberculin skin test (TST) value is the latest test value corresponding to the 
diagnostic ward (DGW) visit. 
6. BAZ: Body mass index (BMI) for age Z-score. Calculated with the help of WHO 
provided software. Under weight – Less than or equal to -2; Over weight – Greater 
than or equal to 1; Normal – Between -2 to 1 (Doesn’t includes -2 & 1) 
 
  
Table 10 represents the association between sputum culture results for NTM (sputum sample 
having NTM species on culture and no NTM growth) with symptoms, history of TB contact 
of participant at the time of DGW visit, gender, socio economic status indicators, BAZ score 
and corresponding TST result. Results for NTM among participants positive for M.tb were 
considered as missing data in the analysis. Male participants had 200% more chance of 
becoming NTM positive on culture of the sputum samples compared to female participants 
with an odds of 1.90 (95% C.I = 1.25 – 2.90). There was 2 times more chance to isolate NTM 
from the participants who belongs to Dalit/ Harijan’s community, the odds ratio was 1.91 
with 95% C.I of 1.18 – 3.11.  
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The 2 participants with presence of haemoptysis for more than 2 weeks at the time of DGW 
visit had isolation of NTM on culture. The association found significant with odds of 5.06 
(95% C.I = 4.30 – 5.96). The GenoType Mycobacterium CM kit had isolated M.fortuitum 
and M.intracellulare from these two participants. There was no significant association found 
with other symptoms suggestive of Tuberculosis and presence of NTM in sputum samples. 
The other socio economic status indicators of the participants and tuberculin skin test (TST) 
also didn’t show any significant association with presence of NTM species.     
 
Table 10: Association of symptoms, age, gender, socio-economic status and other variables 
with MOTT result of the sputum culture 
 
 
Variables  MOTT 
positive 
(n=116) 
1
 
MOTT 
negative 
(n=467) 
2
 
Unadjusted 
Odds ratio 
95% C.I. 
Adjusted  
Odds ratio 
Age category   
12-13 years 
14 – 15 years 
16 – 17 years 
18 – 20 years
®
 
11  (9.5) 
60 (51.7) 
36 (31.0) 
9 (7.8) 
 
56 (12.0) 
250 (53.5) 
118 (25.3) 
43 (9.2) 
 
0.94 (0.32 – 2.74) 
1.15 (0.50 - 2.68)  
1.46 (0.70 - 2.61)  
0.90 (0.44  – 1.88) 
0.69 (0.32 – 1.50) 
1.14 (0.39 – 3.35) 
 
Gender 
Male 
Female 
75 (64.7) 
41 (35.3) 
 
226 (48.4) 
241 (51.6) 
 
1.95 (1.28 – 2.97) 1.94 (1.23 – 3.05) 
Socio-economic characteristics 
Education of Mother 54 (47.0)    
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Illiterate 
Primary 
Secondary or more
®
 
37 (32.2) 
24 (20.9) 
204 (43.7) 
149 (31.9) 
114 (24.4) 
1.26 (0.72 - 2.22) 
1.18 (0.64 – 2.17) 
Education of Father 
Illiterate 
Primary 
Secondary or more
®
 
 
29 (25.0) 
38 (32.8) 
49 (42.2) 
 
 
122 (26.3) 
138 (29.7) 
204 (44.0) 
 
0.99 (0.57 –1.70) 
1.15 (0.69 –1.89) 
 
Type of wall  
Brick 
 others 
 
91 (78.4) 
25 (21.6) 
 
386 (82.7) 
81 (17.3) 
 
0.76 (0.46 –1.26) 
 
Cooking fuel used 
Wood 
Others 
 
101 (87.1) 
15 (12.9) 
 
391 (83.7) 
76 (16.3) 
 
1.31 (0.72 – 2.37) 1.12 (0.59 – 2.12) 
Caste 
Dalit 
Others 
 
30 (25.9) 
86 (74.1) 
72 (15.4) 
395 (84.6) 
1.91 (1.18 – 3.11) 
 
 
2.0 (1.2 – 3.32) 
 
Symptoms 
3
  
Weight Loss  
Yes                                      
No                                   
 
5 (4.3)
111 (95.7)
 
18 (3.9) 
449 (96.1) 
 
1.12 (0.41 – 3.09) 
 
Cough more than 2 
weeks 
Yes 
 
 
9 (7.8) 
 
 
30 (6.4) 
 
 
1.23 (0.57 – 2.66) 
 
1.11  (0.47 – 2.61) 
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No 107 (92.2) 437 (93.6) 
Fever more than 2 
weeks 
Yes 
No 
 
 
3 (2.6) 
113 (97.4) 
 
 
17 (3.6) 
450 (96.4) 
 
 
0.70 (0.20 – 2.44) 
 
Haemoptysis more 
than 2 weeks 
Yes 
No 
 
 
2 (1.7) 
114 (98.3) 
 
 
0 (.0) 
467 (100.0) 
 
 
5.1 (4.32 – 6.01) 
 
Night sweats more 
than 2 weeks 
Yes 
No 
 
 
0 (.0) 
116 (100.0) 
 
 
6 (1.3) 
461 (98.7) 
 
 
1.25 (1.20 – 1.30) 
 
Contact 
4
 
   Yes                              
No 
 
16 (13.8)
100 (86.2) 
 
47 (10.1) 
420 (89.9) 
 
1.43 (0.78 – 2.63) 1.16 (0.59 – 2.26) 
Recent TST value 
5
 
       < 10 mm  
≥10 mm 
 
33 (28.7) 
82 (71.3) 
 
130 (27.8) 
337 (72.2) 
 
1.04 (0.66 – 1.64) 1.01 (0.61 – 1.67) 
BAZ 
6
 
Underweight 
Overweight or Obese 
Normal
®
 
 
58 (50.9) 
2 (1.8) 
54 (47.4) 
 
196 (43.1) 
11 (2.4) 
248 (54.5) 
 
1.36 (0.88 – 2.10) 
0.84 (0.12 – 4.16) 
 
1.27 (0.81 – 1.98) 
1.35 (0.28 – 6.55) 
X ray     
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Abnormal TB 
Not TB 
0 (0.0) 
116 (100.0) 
3 (0.6) 
464 (99.4) 
1.250 (1.20 – 1.30) 
BCG scar status 
Yes 
No 
 
71 (61.2) 
45 (38.8) 
 
298 (63.8) 
169 (36.2) 
 
0.90 (0.59 – 1.36) 
 
 
®: Reference variable 
1. The number denotes the number of participants with NTM positive sputum samples; 
the participants’ sputum samples were positive for culture of Non tuberculosis 
bacteria (NTM) either in day 1 or day 2 or both sputum samples 
2. The participants’ sputum sample was negative for culture of Non tuberculosis bacteria 
(NTM) in both sputum samples. If there was only one sputum sample available and 
negative for NTM, it is also considered as negative for NTM. For 13 participants’ 
sputum samples were not collected as per old protocol, for 1 participant the HAIN 
Genotype was invalid for NTM, 7 participants were positive for M.tb and 5 
participants were showing HAIN genotype as invalid for M.tb. 
3. The symptoms were recorded at the time of diagnostic visit in diagnostic ward 
(DGW). They might not be the referral criteria. 
4. The contact with a positive TB case for more than 8 hours a week. 
5. Recent Tuberculin skin test (TST) value is the latest test value corresponding to the 
diagnostic ward (DGW) visit. 
6. BAZ: Body mass index (BMI) for age Z-score. Calculated with the help of WHO 
provided software. Under weight – Less than or equal to -2; Over weight – Greater 
than or equal to 1; Normal – Between -2 to 1 (Doesn’t includes -2 & 1) 
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Missing Data:  Education of Father – 3 and BAZ – 12 
 
 
5.4.2. Confounder-adjusted estimates: 
 
The Binary logistic regression had shown that the Female participants had 94% less chance to 
be diagnosed as definite TB compared to Male participants. Other associations were not 
changed after logistic regression. The adjusted odds have not changed with definite TB/ 
Probable TB after regression analysis.  
 
The association between presence of NTM species with symptoms, TST result, gender, BAZ 
score, BCG scar status, socio economic status indicators and history of TB contact were 
adjusted with binary logistic regression method. The covariates included in the regression 
method were gender of the participants and age of the participants, cough, type of cooking 
fuel, history of TB contact, TST result and BAZ (Body mass index for age Z – score) score of 
the participant and caste to which the participant belongs. This analysis did not change the 
significant association between the gender and presence of NTM species in sputum and also 
the significant association between the communities to which the participants belong and 
NTM isolation from the sputum sample. The logistic regression also had shown that male 
participants were having 2 times more chance to be positive for NTM species on culture of 
the sputum specimen using GenoType Mycobacterium CM kit compared to the female 
participants. And the sputum from the participants belonging to Dalit community had 2 times 
more chance to isolate NTM species using the GenoType Mycobacterium CM kit. Table 8, 9 
and 10 gives the adjusted estimates. 
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5.5. Other analysis: 
Among all the participants attended the diagnostic ward, 19 participants had DGW visits 
more than once. Of these 19, one participant attended the DGW, 3 times was positive for 
sputum AFB smear only during the 3
rd
 visit. The participant was also positive for culture of 
M.tb only during the 3
rd
 visit. The same participant was showing chest x-ray abnormal for TB 
during 2
nd
 and 3
rd
 visit to the DGW. One participant had chest x-ray abnormal, not TB during 
the 1
st
 visit to the DGW whose X-ray was normal in following visit. All other participants 
had normal chest x-ray. 1 participant was positive for NTM (M.intracellulare) on culture of 
day 1 sputum sample during the 1
st
 visit. Three participants were positive for NTM on culture 
of day 2 sputum samples during their 1
st
 visit. One participant was positive for NTM on 
culture of day 2 sputum sample during latest visit (2
nd
 visit).  
 
Table 11 explains the characteristics between the participants with single visits to the DGW 
and the participants with multiple visits. Among all the participants, the participants who 
attended the DGW more than once were more likely to be older age group, belonging to 
Muslim religion, part of active surveillance of the study and had a significant exposure to TB. 
Except these differences, the participants who visited the DGW more than once are 
characteristically similar to the participants who attended only once to the DGW during the 2 
year follow-up. 
 
Table 11: Comparison of characteristics between the participants with single visit to DGW 
and multiple visits (2 or more visits) to DGW.  
 Single Visit (N = 
590) 
Multiple visits 
(N=19) 
 
Age    
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12 - 13 years 70 (11.9 %) 0 (0.0 %)  P = 0.01 
14 – 15 years 322 (54.6%) 7 (36.8%)  
16 – 17 years 150 (25.4%) 7 (36.8%)  
18 – 120 years 48 (8.1%) 5 (26.3%)  
    
Gender    
Male 299 (50.7%) 11 (57.9%) P = 0.536 
Female 291 (49.3%) 8 (42.1%)  
    
Religion    
Hindu 530 (89.8%) 12 (63.2%) P < 0.001 
Muslim 52 (8.8%) 7 (36.8%)  
Christian 8 (1.4%) 0 (0.0%)  
    
Caste    
Dalit/ Harijan 105 (17.8%) 5 (26.3%) P = 0.342 
Others 485 (82.2%) 14 (73.7%)  
    
Walls     
Brick 483 (81.9%) 16 (84.2%)  P = 0.808 
Others 107 (18.1%) 3 (15.8%)  
    
Surveillance group    
Active 320 (95.2%) 16 (84.2%) P = 0.01 
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Passive 270 (98.9%) 3 (15.8%)  
    
Cooking Fuel    
Wood 495 (83.9%) 16 (84.2%) P = 0.971 
Others 95 (16.1%) 3 (15.8%)  
    
Exposure to TB (≥ 8 
hours per week) 
   
Yes 62 (10.6%) 5 (26.3%) P = 0.03 
No 524 (89.4%) 5 (73.7%)  
    
Education of Mother    
Illiterate 260 (44.2%) 10 (52.6%) P = 0.768 
Primary 187 (31.8%) 5 (26.3%)  
 Secondary or more 141 (24.0%) 4 (21.1%)  
Education of Father    
Illiterate 150 (25.6%) 7 (38.9%) P = 0.162 
Primary  182 (31.0%) 2 (11.1%)  
Secondary or more 255 (43.4%) 9 (50.0%)  
 
 
The participants who attended the DGW were characteristically similar to the participants 
who didn’t attend the DGW during the follow-up even though they had been referred. Except 
that, the male participants were more likely to deny for attending the DGW for diagnosis of 
TB compared to female. Table 12 gives the details of the same. 
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Table 12: Comparison of characteristics between the participants screened for TB disease and 
not screened for TB disease.   
 
 Screened for TB 
disease 
(Responders)  (N = 
609) 
Not Screened for Tb 
disease 
1
 (Non 
Responders) (N = 733)  
 
Age
2
    
12 years 176 (28.9 %) 176 (24.0%)  P = 0.217 
13 – 14 years 312 (51.2%) 392 (53.5%)  
15 – 16 years 96 (15.8%) 130 (17.7%)  
17 – 18 years 25 (4.1%) 35 (4.8%)  
    
Gender    
Male 310 (50.9%) 429 (58.5%) P = 0.005 
Female 299 (49.1%) 304 (41.5%)  
    
Religion    
Hindu 542 (89.0%) 650 (88.7%) P = 0.149 
Muslim 59 (9.7%) 80 (10.9%)  
Christian 8 (1.3%) 3 (0.4%)  
    
Caste    
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Dalit/ Harijan 110 (18.1%) 141 (19.2%) P = 0.583 
Others 499 (81.9%) 592 (80.8%)  
    
Walls     
Brick 499 (81.9%) 582 (79.4%)  P = 0.242 
Others 110 (18.1%) 151 (20.6%)  
    
Surveillance group    
Active 336 (55.2%) 373 (50.9%) P = 0.117 
Passive 273 (44.8%) 360 (49.1%)  
    
Cooking Fuel    
Wood 511 (83.9%) 636 (86.8%) P = 0.139 
Others 98 (16.1%) 97 (13.2%)  
Education of Mother    
Illiterate 270 (44.3%) 351 (47.9%) P = 0.194 
Primary or more 339 (55.7%) 382 (52.1%)  
    
Education of Father
3 
   
Illiterate 157 (26.0%) 217 (21.7%) P = 0.119 
Primary or more 448 (74.0%) 511 (70.2%)  
1: Includes withdrawn participants;  
2: Age of the participant at the time of enrolment i.e. at Day 0. 
3: For 9 participants the education of father is missing 
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Table 13 gives the information regarding the demographic details of the participants who 
didn’t attend the diagnostic ward even though they had referral criteria. The participants were 
categorized into group of participants withdrawn from the study and group of participants 
who were active during the entire 2 year follow-up. Participants who were withdrawn were 
most likely to be older age group and were in active surveillance of the study. Otherwise the 
two groups were distributed equally in gender wise and other socioeconomic characteristics 
wise.   
 
 
Table 13: Comparison of the demographic details of participants withdrawn from the study 
and active during the follow-up among participants who didn’t attend the DGW even after 
referral from the field  
 
 Active
1
 (%) 
(N = 454) 
Withdrawn 
2
(%) 
(N = 279) 
 
Age
3
    
12 years 131 (28.9) 45 (16.1) P < 0.001 
13 – 14 years 239 (52.3) 153 (54.8)  
15 – 16 years 66 (14.5) 64 (22.9)  
17 – 18 years 18 (4.0) 17 (6.1)  
    
Gender    
Male 270 (59.5) 159 (57.0) P = 0.508 
Female 184 (40.5) 120 (43.0)  
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Religion    
Hindu 401 (88.3) 249 (89.2) P = 0.925 
Muslim 51 (11.2) 29 (10.4)  
Christian 2 (0.4) 1 (0.4)  
    
Caste    
Dalit/ Harijan 91 (20.0) 50 (17.9) P = 0.479 
Others 363 (80.0) 229 (82.1)  
    
Walls     
Brick 356 (78.4) 226 (81.0) P = 0.4 
Others 98 (21.6) 53 (19.0)  
    
Surveillance group    
Active 217 (47.8) 156 (55.9) P = 0.03 
Passive 237 (52.2) 123 (44.1)  
    
Cooking Fuel    
Wood 401 (88.3) 235 (84.2) P = 0.11 
Others 53 (11.7) 44 (15.6)  
    
Education of Mother    
Illiterate 225 (49.6) 126 (45.2) P = 0.25 
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Primary or more 229 (50.4) 153 (54.8)  
    
Education of Father
4 
   
Illiterate 129 (28.6) 88 (31.8) P = 0.37 
Primary or more 322 (71.4) 189 (68.2)  
1: Active group participants were those who continued in the study during two years follow-
up. 
2: Participants withdrew from the study during the two years follow-up. 
3: Age of the participant at the time of enrolment i.e. at Day 0. 
4: For 5 participants the education of father was missing data 
 
6. Discussion: 
6.1. Validity: 
6.1.1. Internal Validity: 
 
6.1.1.1 Selection Bias: All the study participants were school going children and were 
distributed evenly with respect to age and gender. The data regarding for some variables 
mentioned below were missing; education of mother in 1 participant, education of father in 3 
participants, information regarding history of weight loss in one participant, night sweats in 1 
participant, history of significant TB contact in 14 participants, recent TST result was not 
available for 1 participant and BMI for age Z – score was not available for 15 participants. 
We considered the missing data of these will not change the output in the analysis.   All the 
participants had referral criteria, at the time of DGW visit. 5 participants attended the DGW 
directly, without referral letter from the field. These participants were considered as “self-
referral” participants. Of these 5 participants, 3 had symptoms and 2 participants had history 
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of TB exposure which met our referral criteria. Among all the visits to DGW by a participant, 
we considered only latest visit in order to maintain even distribution and uniformity of the 
data.  
 
6.2.1.2 Information Bias: The information regarding the clinical history was collected from 
participants themselves in 65%. For 27% of participants, it was the parents and remaining 8% 
it was grandparents or other relatives who provided the information.  
 
Among 13 participants who attended the DGW before the restart of the study, as per old 
protocol the sputum was not collected because the chest x-ray was normal and the physician 
who examined the participant decided not to process the sputum sample for Acid fast bacilli 
smear or culture. So for these participants sputum samples were not collected. The data for 
these participants was considered as missing data. Among 609 participants, for 6 participants 
the Genotype Mycobacterium CM report for Mycobacterium tuberculosis complex was 
invalid. So for these 6 participants the data was considered as missing data. We have ignored 
the potential yield of these 19 participants (13 and 6 participants, total 19 participants) and 
considered the inclusion of these in the analysis will not change the output results.  
 
For 4 participants whose sputum samples were contaminated (either day 1 or day 2), the 
uncontaminated sputum sample culture result was considered in the analysis. 
 
The confounding for outcome measures was controlled with Binary logistic regression. The 
effect measures were adjusted for Socio economic status indicator (Walls type of the houses, 
cooking fuel used for cooking), gender, age, cough for more than or equal to 2 weeks, recent 
TST result, Body mass index Z – scores and recent contact with TB.  
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6.1.2. External Validity (Generalizability): 
 
The study participants were all school going children residing in semi urban and rural areas. 
The results were internally valid among the participants, so the results can be applied to 
school going adolescent in India and other high TB prevalent countries.  
The National family health survey (NFHS – 3), India (2005 – 06) had shown that only 41% 
of adolescents between age 15 – 17 years were attending the school in year 2005 – 06 (48). 
This study was conducted only in school going children, which restricts the generalizability 
of the results. We cannot apply the results for all the adolescent age group in India.  
 
6.2: Sampling:  
 
The participants were referred to the diagnostic ward (DGW) as part of the prospective cohort 
study. The schools in the study area were selected in a random sampling procedure to include 
in the study. The selected schools were assigned to either active or passive surveillance 
methodology after a stratified randomization procedure. After the randomization, eligible 
participants from schools were invited to participate in the study. A total of 6643 participants 
were enrolled and of this 609 participants attended the DGW.    
 
The nonparticipation of participants to DGW for TB diagnostic evaluation, who had referral 
criteria, might have affected the output results. As the study is the part of vaccine trials, it was 
started with the main objective of looking at the incidence of definite TB in the study group. 
In the course of study the number of incident cases was less than the number that was 
anticipated before the start of study. So the referral criterion has been revised and instead of 
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TST more than 15 mm as per the old protocol, TST value of more than 10 mm was 
considered as referral criteria. Some of the participants have completed their two years 
follow-up by the time decision of this revision was taken. Due to this reason even though 
there were 1343 participants who had referral criteria, only 609 (45.4%) participants attended 
the DGW. The remaining 733 (54.6%) did not attended the DGW for the TB evaluation. The 
male participants were more likely to non-participate the DGW for TB evaluation compared 
to female participants. In other characteristics both the groups (Participants who attended the 
DGW and who didn’t attend the DGW even though they were referred to DGW) were 
similar.   
 
6.3. Main Results: 
 
6.3.1: Definite and Probable Tuberculosis: 
 
The present study had shown that 1.15 percentages of adolescent participants were diagnosed 
as definite TB. The proportion of probable tuberculosis among the participants was 0.5 %. 
Both probable and definite Tuberculosis together, accounts for 1.64 percentages. This 
proportion of the cases detected in our study was less compared to RNTCP estimation, in 
2007 and what other studies had shown. 14% of TB suspects (Includes all age groups) in 
Chittoor district were sputum positive TB cases in 2007 where the study was conducted (31).  
The figure we got in the study might be the under estimation of the true proportion of TB in 
the community. This may be because we have taken only the school going children in the 
study, but the burden is more among the school dropout children.  There might be one more 
reason for this under estimation of the true result, that is, most of the participants who were 
referred to the DGW did not show up for the TB diagnostic tests.  
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The study conducted among tribal population of Madhya Pradesh, in 2007 - 08 had shown 
that 4.4 percentage of the participants between 15 – 24 years of age group, who had 
symptoms suggestive of TB, were sputum positive(29). The wide gap in the above results 
with our results can also be explained by following reasons:  
1. In RNTCP there are only symptomatic patients and there were no Tuberculin skin test 
positive patients. We have considered culture positive for M.tb as definite TB unlike 
only smear positive in RNTCP. 
2. In RNTCP, the results apply to all age groups, not only in school going adolescent 
children.  
3. The study conducted in Madhya Pradesh shows the results among tribal population 
which is demographically different from our study population. 
4. The less proportion of the definite and probable Tuberculosis cases can be implicated 
to the uniqueness among the school going adolescent children. 
In our study, the univariate analysis had shown that participants with presence of cough for 
more than or equal to 2 weeks had 19 times more chance to be diagnosed as definite TB and 
9 times more chance to be diagnosed as either definite TB or probable TB. The retrospective 
study conducted by Wong et al, had shown that the adolescents who had cough for more than 
4 weeks had an increased risk of acid fast bacilli smear positivity. The odds ratio was 13.8 
with 95% C.I = 2.3 – 83.1 (49). Unlike the earlier study, in our study we used culture and 
molecular DNA test to diagnosis pulmonary TB. Even then our findings are similar to the 
previous studies. The review article by Cruz AT and Starke JR also states that among 
adolescents cough is more common symptom(19). This supports that among adolescents 
cough more than two weeks is characteristic symptom. 
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In our study the univariate analysis has shown that presence of recent weight loss at the time 
of diagnostic ward visit among participants is one of the characteristic symptoms for 
diagnosis of pulmonary TB among adolescents. They are 18 times more likely to be 
diagnosed as definite TB and have 17 times more chance to be diagnosed as either definite 
TB or probable TB. This finding in our study is similar to the previous papers (19). 
 
 Fever for more than 2 weeks also found to be an important symptom for tuberculosis among 
our study population. The baseline disease survey conducted in South India has shown that, 
fever for more than 1 month doesn’t have significant role in diagnosing pulmonary 
tuberculosis(50). The study group in this survey was aged more than 15 years which is 
different from our study. This paper didn’t discuss the presence of recent loss of weight and 
night sweats among the pulmonary TB cases. In our study the participants with night sweats 
for more than two weeks were found to be more likely to be diagnosed as definite TB or both 
definite and probable TB. But the lower limit of 95% confidence interval is nearer to 1, which 
denotes that association is weak. 
 
We couldn’t elicit any other association among participants who were diagnosed as definite 
TB or probable TB with characteristics like gender, age, TB exposure, socio economic status 
indicators, tuberculin skin test result and body mass index for age Z – score. The study 
conducted by Kolappan C et al among individuals aged more than 15 years, in South India 
had shown that males have 2.5 times more chance to be diagnosed with pulmonary TB 
compared to females(51). The same finding was not observed in our study. This can be 
implicated to the peculiarity of the characteristics of school going adolescent age group. The 
matched case – control study conducted in St. John’s Medical college hospital, Bangalore 
have found that lack of separate cooking facilities was a risk factor for tuberculosis and 
75 
 
higher education level was significantly protective against tuberculosis(52). Because of this 
we looked at the education levels of both parents of the participants and the association with 
definite TB and either definite or probable TB and we didn’t find any association. The study 
conducted by Mishra VK et al. in 1992 - 93 found that biomass cooking fuel increases the 
risk of tuberculosis (53).  In our study we didn’t find any association between the biomass 
cooking fuel and Tuberculosis.    
We found that there were three participants who didn’t have any symptoms at the time of 
DGW visit but were diagnosed as definite TB. This can be attributed to the primary infection 
of tuberculosis which may have progressed to disease without symptoms. This can be 
implicated to shortest time interval between primary tuberculosis infections to the 
development of disease which is more common among adolescents with minimal or no 
symptoms at starting of the disease as described by B.J Marias, R.P. Gie et al (IJTLD – 2004) 
(54).  
 
6.3.2. Nontuberculous Mycobacteria (NTM) isolates: 
 
In our study we found that 19.2 % of the participants’ sputum samples were positive for 
Nontuberculous Mycobacteria (NTM). This is much higher than the previous studies, which 
had shown the isolation rates of NTM in south India and North India (9, 11, 13). The study 
conducted by Karak et al in Calcutta, India has reported that 17.4% of sputum specimens 
from fibrocavitary lung diseases have yielded NTM (55). The high ambient temperature 
present in major parts of South India encourages the growth of Mycobacteria in the 
environment (9, 11). Because of this, confirmation of the NTM infection must be done with 
positive culture from at least two separate sputum samples (4). But in our study the NTMs 
were isolated from single occasion. None of the participants whose culture results positive for 
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NTM had chest X- ray abnormalities. So as with other studies we consider that these NTM 
are either by chance or by the contamination of sputum samples by environmental 
Mycobacteria (11). These isolates therefore had no clinical significance. 
    
In our study we found that male had 2 times more risk of getting infected with NTM as 
compared to females.  The same finding is also found in previous studies (14). This gender 
difference can be attributed to the wide exposure of the male to the environment compared to 
females in South India because of the social and economic disparities.  The studies have also 
shown that increasing age is  a risk factor for the NTM infection (14). But in our study we 
couldn’t find any association with increased age from 11 years to 20 years among the 
adolescent participants.  
 
We found that the participants belonging to Dalit community have a 2 times higher chance of 
getting infected with NTM compared to participants belonging to other communities. This is 
because of low levels of hygiene in the same population. This can be attributed to the low 
socio-economic status of the Dalit community population in South India (NFHS -3, 2005 – 
06).   
 
The high proportion of particular species like M.fortuitum, M.intracellulare and 
M.scrofulaceum in our studies is similar to the rate of the isolates in other earlier studies (11-
12, 55). This finding in our study signifies that the NTM prevalence among adolescent age 
group is similar to the general population in South India. 
The current study has found that the participants who had haemoptysis for more than 2 weeks 
have 5 times higher chance of producing NTM isolates from the sputum samples. These two 
participants yielded M.fortuitum and M.intracellulare from the sputum samples. These 
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Mycobacteria might be responsible for producing haemoptysis in those participants. It is 
known that M.intracellulare and M.fortuitum are pathogenic Mycobacteria and produces 
pulmonary disease (4). But in our study we didn’t repeat the test to isolate the same species 
from another sputum sample, so the significance of these Mycobacteria can’t be ascertained.  
 
6.4. Conclusion: 
 
6.4.1. For Research: 
6.4.1.1: Mycobacterium tuberculosis: 
Even though the current study has shown a lower proportion of TB disease among the school 
going adolescents in South India, there must be further studies to ascertain the actual burden 
among all the adolescent age groups which includes the adolescents who do not go to school. 
6.4.1.2. Nontuberculous Mycobacteria: 
The NTM detected in our study had no clinical significance. There must be further studies to 
find out the clinical significance of NTM among the adolescent age groups with confirmation 
of NTM infection according to the clinical, microbiological and radiological criteria. 
 
6.4.2. For practice/ policy: 
6.4.2.1: Mycobacterium tuberculosis: 
The National Tuberculosis control programmes have to be strengthened among the school 
going adolescent age groups because of the vulnerability of the adolescents towards 
Tuberculosis disease. 
6.4.2.2. Nontuberculous Mycobacteria: 
The NTM is more common among the Dalit community; this might be because of their living 
conditions, which have to be improved. The findings in our study suggest that the NTM 
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situation among adolescent is not different from the general population in South India. The 
exposure to the NTM must be considered during the conduction of new vaccine trails among 
the adolescents, because it may affect the vaccine efficacy.  
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Appendix A - DAY 0 Questionnaires: 
 
 
INFORMED CONSENT PROCESS  
 
 
Date of consent discussion:          __ __ / __ __ / __ __ __ __ 
       d d         m m             y y y y  
 
Village name 
 
 
______________________________ 
 
School/College name 
 
 
 
 
Parent’s name   
 
 
Address and Contact details 
 
 
 
 
 
 
Land line:_____________________ 
 
Mobile:________________________ 
 
E-mail:________________________ 
Adolescent’s  Details 
 
Reported Age:____ ____Yrs 
 
Initials:____ ____ ____ 
 
Was ADEQUATE TIME given for parent/ 18 year old adolescent’s 
consideration, questions, and answers? 
  YES   NO 
Does parent/ 18 year old adolescent express understanding of the 
PURPOSE of the study? 
  YES   NO 
Does parent/18 year old adolescent express understanding that 
participation is VOLUNTARY? 
  YES   NO 
Does parent/ 18 year old adolescent express understanding WHAT 
PARTICIPATION INVOLVES? 
  YES   NO 
Does parent/18 year old adolescent express understanding of the 
difference between ACTIVE and PASSIVE follow-up? 
  YES   NO 
Does Parent know that their child will also be discussed separately 
about the study and their participation? (Check NA in the case of 18 old 
adolescent) 
  NA   YES   NO 
Does parent/18 year old adolescent give permission to review the school 
and or other records for an official date of birth? 
  YES   NO 
Was Informed Consent signed? 
 
If YES, date consent signed: __ __ / __ __ / __ __ __ __ 
                                            d d         m m             y y y y 
  YES   NO 
If NO, record the reason  
 
Record approximate length of time taken to complete Informed Consent 
Process. 
 
 
 
 
________________________________________________________________________________________________________________ 
Name of study team member who conducted consent process  
 
 
________________________________________________________________________________________________________________ 
Signature of study team member who conducted consent process   Date 
 
 
INFORMED ASSENT PROCESS Study Team Member Code 
 
   
Enter # recorded on page 3 only if child is enrolled in study. 
PID #  ___  ___   --  ___  ___  ___   
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(Only if adolescent is less than 18years of age) 
  
 
 
Date of assent discussion:          __ __ / __ __ / __ __ __ __           Or           NA 
     d d         m m             y y y y  
 
Version of the consent used:     
                                           Original/ same language as consent form ( for the age group between 15-17) 
                                                         Simplified version of the consent ( for the age group between 12-14) 
 
Was ADEQUATE TIME given for adolescent’s consideration, questions, 
and answers? 
  YES   NO 
Does adolescent express understanding of the PURPOSE of the study?   YES   NO 
Does adolescent express understanding that participation is 
VOLUNTARY? 
  YES   NO 
Does adolescent express understanding WHAT PARTICIPATION 
INVOLVES? 
  YES   NO 
Does adolescent express understanding of the difference between ACTIVE 
and PASSIVE follow-up? 
  YES   NO 
Is adolescent interested to participate?   YES   NO 
Was Informed Assent signed? 
 
If YES, date assent signed: __ __ / __ __ / __ __ __ __ 
                                            d d         m m             y y y y 
  YES   NO 
If NO, record the reason  
 
Record approximate length of time taken to complete Informed assent 
Process. 
 
 
 
 
 
________________________________________________________________________________________________________________ 
Name of study team member who conducted assent process  
 
 
________________________________________________________________________________________________________________ 
Signature of study team member who conducted assent process   Date 
 
 
 
 
 
 
Study Team Member Code 
 
   
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SCREENING and ENROLLMENT 
 
 
Date of screening/enrollment (Study Day 0):    __ __ / __ __ / __ __ __ __ 
                                                                                  d d         m m             y y y y 
 
Adolescent’s date of birth 
 
 
    __ __ / __ __ / __ __ __ __ 
d d         m m             y y y y 
 
Adolescent’s 
Gender 
M or F 
 
______ 
 
Name of the School/College 
 
 
 
Grade(7 to 12):_____  _____ 
 
Was copy of signed consent given to parent or 18 year old 
adolescent? 
  YES   NO 
Was copy of signed assent given to adolescent?   NA   YES   NO 
Does family plan to live within study area for next 2 years?   YES   NO 
Is adolescent able to attend follow-up visit for reading Mantoux 
test?   
  YES   NO 
Does adolescent meet all eligibility criteria?   YES   NO 
 
If YES, record sequentially assigned PID #    ____   ____   -   ____   ____   ____   
 
Surveillance group assigned to:        ACTIVE                      
 
                                                           PASSIVE 
 
 
If NO, do not assign a PID #; Record reason not enrolled: 
 
 
 
Give parent completed Study Participant ID Card.  Review the contact information noted on the 
card with them. Tell parent and or participant to bring the PID card and show when ever they 
contact the physician or the study staff. 
 
The adolescent is considered enrolled in the study when the PID # is assigned.  From 
this point forward, use the initials and the PID # as identifiers of the adolescent.  
 
 
 
 
________________________________________________________________________________________________________________ 
Name of study team member who conducted screening and enrollment process  
 
 
________________________________________________________________________________________________________________ 
Signature of study team member who conducted screening and enrollment process  Date 
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STUDY DAY 0  
 
 
Socio-economic factors: 
 
Religion:  
      Hindu 
     Muslim 
     Christian 
     Sikh 
     Jain 
     Buddhist 
     Other; specify:  ________________________________________________  
     Not answered 
 
 
Caste:  
     Dalit/Harijan    
     Others 
     Not answered 
   
 
Highest level of education attained:    
   
        Mother:                                                                Father:     
       Illiterate                     Illiterate 
       Primary          Primary 
       Secondary        Secondary 
       High school       High school 
       Higher secondary       Higher secondary 
       College        College 
         Not answered       Not answered 
 
Occupation:   
 
                              
Mother:  _____________________________   Or,    Not answered 
 
                 
Father:    _____________________________   Or,    Not answered                
 
 
 
What is the total monthly household income?  ______________ Rupees Or,     Not answered 
 
 
 
 
 
 
 
 
 
 
Completed by 
Headquarters 
          
          
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STUDY DAY 0 (continued) 
 
 
 
What are the walls of the house made of?             
 
                                                                                 Packed mud  
                    Stone 
        Bamboo 
        Thatch 
        Wood 
        Brick 
        Other; specify:  ________________________ 
        Not answered 
 
 
Does the house have an electricity connection?     
                                                                     Yes        
          No       
         Not answered 
 
 
Which type of fuel is used as major cooking fuel? 
 
                                                   LPG  
                                               Electricity 
                                               Wood 
                                               Kerosene 
                                               Coal 
                                               Agricultural residue 
                                               Others, Specify_______________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study Team Member Code 
 
   
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STUDY DAY 0(continued) 
Details of BCG Immunization: 
Was participant immunized with BCG?   
        Yes  
                                           No   
                                             Not known 
                                            Not answered 
 
 
 
 
 
 
History of TB disease 
Any YES answer either from the parent or from 
the participant has to be considered as positive 
 
 
Did your child/you have TB disease in the past  
 
 
 
 
 
Is your child/ Are you currently taking TB 
medications 
If YES Mantoux should not be applied 
 
 
History of positive TB contact  
(for more than 8 hrs/week) 
 
 
Symptoms for more than two weeks 
Unexplained Cough  
 
 
Unexplained Weight loss 
 
 
 Unexplained Fever 
 
 
Unexplained Night sweats 
 
 
Haemoptysis(Blood seen in mucous when 
cough) 
 
 
Hospital admission(in the past six months for 
any illness) 
Parent interview 
 
 
 
Participant interview 
 
 
 
 
 Yes, indicate the 
age of the 
child____ 
 No 
 Not known 
 
 Yes 
 No 
 Not known 
 
 Yes 
 No 
 Not known 
 
 
 
 Yes 
 No 
 
 Yes 
 No 
 
 Yes 
 No 
 
 Yes 
 No 
 
 Yes 
 No 
 
 
 Yes 
 No 
 
 Yes 
 No 
 Not known 
 
 
 
 Yes 
 No 
 Not known 
 
 Yes 
 No 
 Not known 
 
 
 
 Yes 
 No 
 
 Yes 
 No 
 
 Yes 
 No 
 
 Yes 
 No 
 
 Yes 
 No 
 
 
 Yes 
 No 
 
Study Team Member Code 
   
Study Team Member Code 
   
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STUDY DAY 0 (continued) 
 
Diagnosis of any acute or chronic diseases 
in the past  
 
Gastro enteritis 
 
 
 
 
Pneumonia 
 
 
 
 
Meningitis 
 
 
 
 
Asthma                                                          
 
 
 
 
Diabetes 
 
 
 
 
Anemia 
 
 
 
 
Others  
 
 
 
 
 
If any of the above answers is YES then 
check YES otherwise check NO 
Parent interview 
 
Participant interview 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
If YES specify: 
_____________________ 
 
 
 Yes 
 No 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
 Not known 
 
 
 Yes 
 No 
If YES specify: 
_____________________ 
 
 
 Yes 
 No 
 
 
Name of family doctor: __________________________________________          Or,     None 
 
Location: __________________________________________ 
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STUDY DAY 0 (continued)    
Physical measurements 
 
 Weight: ___ ___ ___.  ___ Kg 
 
 Height: ___ ___ ___.  ___ cm 
__________________________________________________________________________________
__ 
 
Presence of BCG scar 
 
Whether BCG scar is present?  
                  Yes     
                                                                   No   
__________________________________________________________________________________
___ 
 
Blood Draw for Research of Immunology of TB  
 
Draw the blood before applying the Mantoux. Blood should be collected and labeled as per instruction. Not 
more than two trails should be made for the blood draw. 
 
Date of blood draw:___ ___/ ___ ___/ ___ ___ ___ ___  
                                     dd  mm yyyy       
 
Time of blood draw (use 24 hour clock): ___ ___ : ___ ___ 
                     hh     mm 
 
 Number of CPT tubes used for blood collection: 
 
        1 
        2 
        3 
 
If the number of tubes is less than 3 fill the Protocol Deviation Form. CPT tubes should be kept in the 
cool box to maintain temperature at 2-8°C and transport to the Lab within 4 hours from the time of collection. 
 
 
Blood collected for Serum preparation: 
                                                                      
                                                      Yes     
                                                                   No  
 
 
Hemoglobin concentration: 
 
                               ____ ____   -   ____ g/dL 
 
 
  
   
          
 
 
 
Study Team Member Code 
 
   
Study Team Member Code 
 
   
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STUDY DAY 0(Continued)  
 
 
Tuberculin skin test:   (If the adolescent is taking TB medication then check NA. Test will be read within 2 – 4 days after 
application.  Test should be applied after the blood draw.) 
 
   Date applied:   __ __ / __ __ / __ __ __ __     Or        NA                    
                                        d d            m m             y y y y 
 
   Time applied (use 24 hour clock):__ __ : __ __ 
      h h           m m  
 
 
   Date read:   __ __ / __ __ / __ __ __ __ 
                d d           m m             y y y y                                
 
   Reading time (use 24 hour clock):__ __ : __ __ 
                               h h           m m  
 
Result (Record widest transverse measurement in whole number):  ___ ___ mm       
 
If the Tuberculin skin test reaction is less than 5mm apply the second test 1-4 weeks after the first test was applied to the opposite arm. The 
larger  
will be used as baseline value. 
 
________________________________________________________________________________________________________________
__ 
Name     Signature      
 
 
 Repeat Tuberculin skin test (If the first test result is less than 5mm repeat the test 1-4 weeks after the first 
test was applied to the opposite arm) 
 
   Date applied:   __ __ / __ __ / __ __ __ __    Or        NA                   
                                        d d            m m             y y y y 
 
   Time applied((use 24 hour clock):__ __ : __ __ 
                              h h           m m 
 
   Date read:   __ __ / __ __ / __ __ __ __ 
                d d           m m             y y y y                                
 
   Reading time (use 24 hour clock):__ __ : __ __ 
                              h h           m m  
 
Result (Record widest transverse measurement in whole number): ___ ___ mm       
 
 The larger result will be used as baseline value. 
 
________________________________________________________________________________________________________________
__ 
Name     Signature      
 
Baseline (write the first tuberculin skin test result as the baseline value if it is more than 5mm otherwise compare first and 
second test results; use the larger result as baseline value.) 
 
Baseline value:___ ___  mm 
 
 
  
 
Study Team Member Code 
 
   
Study Team Member Code 
 
   
Study Team Member Code 
 
   
Study Team Member Code 
 
   
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STUDY DAY 0 (continued) 
 
Sputum Collection: 
 
Is the participant able to provide spot sputum sample? 
 
                                                           YES 
                                                           NO, provide the sputum container with appropriate label, 
(including        PID# and participant initials; and 
instructions for sputum collection) 
                                                                                                                
Date of Early morning Sputum Collection: __ __  /__  __/ __ __ __ __  Or    NA 
 
 
The date on which the baseline evaluations such as Blood collection, TST and or the 
sputum are made is considered as Study Day 0. 
 
If the adolescent has been enrolled in the ACTIVE group, remind adolescent of the date 
for the next scheduled study visit, Study Day 90.   
 
Adolescents enrolled in the PASSIVE group will not have a scheduled study visit until 
Study Day 720. 
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STUDY DAY 0 (continued) 
 
Referral for TB evaluation 
 Was participant referred to TB evaluation? 
      Yes, check the reason for Referral 
         Positive symptoms and Positive 
TST 
         Positive AFB smear  
      No 
   
If YES, has the zone supervisor been informed?              Yes    No 
 
Date of referral: __ __ / __ __ / __ __ __ __ 
     d d            m m             y y y y 
 
Has referral slip been sent for TB evaluation?         Yes    No          Not known  
            
  
 
 
 Education 
 
 Was a list of TB symptoms given to Adolescent and explained about the need to seek treatment?     
   
   Yes          
   No   
   
 
  Reminder to adolescent 
 
 Adolescent will be reminded to inform their parents and contact either study staff or their family 
doctor or a TB clinic or study office (contact number printed on Study ID Card) if they have any of 
these symptoms in future as:    
  
(Check to indicate adolescent was reminded)   
 
   Unexplained cough for two weeks or more  
   Unexplained weight loss for two weeks or more 
   Unexplained fever for two weeks or more  
   Unexplained night sweats for two weeks or more 
   Haemoptysis 
   
 
STUDY DAY 0 NOTES:   ___________________________________________________________ 
_________________________________________________________________________________ 
_________________________________________________________________________________________ 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
_________________________________________________________________________________ 
 
________________________________________________________________________________   
Name         Signature     Date   
 
 
 
Study Team Member Code 
 
   
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Appendix B – DGW Questionnaires: 
 
              
                    DIAGNOSTIC VISIT 
                                                                
 
 
Date of Diagnostic visit:    __ __ / __ __ / __ __ __ __ 
                    d d        m m              y y y y 
 
Referral from (check one):  Self-referral         
    Active follow-up visit         
    Passive surveillance (check one):   
         Hospital/primary health centre/private practitioner     
          Microscopy centre;    Emmaus Swiss Hospital  
            Other 
                                                          Field study team (between scheduled visits for Active group, or 
passive surveillance for Passive group) 
 
                                         Study Day 0 
                                                          Positive AFB smear 
                                                          Positive symptoms and Positive TST 
 
  TST conversion 
              
 
 
 
 
 
Physical assessment   Date of assessment     __ __ / __ __ / __ __ __ __   
(Place leading zero if necessary.)     d d           m m              y y y y                      
          
   Weight ___ ___ ___ . ___  kg 
 
   Height ___ ___ ___ . ___ cm   
  
   Temperature  ___ ___ . ___ °C 
 
   Heart rate ___ ___ ___ bpm    
 
   Blood pressure ___ ___ ___ mm of Hg 
 
   Mid-arm circumference ___ ___ . ___ cm 
 
                                              
 
 
 
 
 
 
 
 
 
 
 
 
Study Team Member Code 
 
   
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          DIAGNOSTIC VISIT (continued) 
                                                                
 
Participant interview  
 
Date of interview     __ __ / __ __ / __ __ __ __  
              d d           m m              y y y y     
 
Is participant experiencing:   
 
Recent illness              
                                     Yes; specify________________________________ How many days 
______       
            Treated:    Yes; specify treatment 
________________________________ 
                                             No  
             No    
 
 
Recent loss of weight             Yes     
                               No 
 
Cough                          Yes; how many days ______       
            Treated:    Yes; specify treatment 
________________________________ 
                                                         No  
             No     
 
 
Fever                            Yes; how many days ______       
          Treated:    Yes; specify treatment 
________________________________ 
                                          No  
             No    
 
 
Haemoptysis                Yes; how many days ______       
          Treated:    Yes; specify treatment 
________________________________ 
                                          No  
             No  
 
 
Night sweats                Yes; how many days ______       
          Treated:    Yes; specify treatment 
________________________________ 
                                          No  
             No    
 
Was the child diagnosed with TB prior to diagnostic visit?    
       Yes, if Yes is the participant currently taking any TB medication?,  
                           Yes; number of days already on treatment:  ______ 
days     
                                                  (Record on TB Treatment Record case report form.)     
                                     No  
       No               
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    DIAGNOSTIC VISIT (continued) 
                                                                 
 
Significant exposure (e.g. approximately 8 hours) to an individual on TB treatment 
   
            Yes     
            No 
 
 Respondent/source of information (check all that apply):     
            Mother    
             Father     
             Grand parent    
                                    Adolescent    
             Other; specify: 
___________________________________________________ 
 
 
 
           
 
     
 
Brief review of systems: physical exam 
 
HEENT        Normal        Abnormal, specify: 
______________________________________ 
 
Dermatologic        Normal        Abnormal; specify: 
______________________________________ 
 
Neurologic        Normal        Abnormal; specify: 
______________________________________ 
 
Respiratory        Normal        Abnormal; specify: 
______________________________________ 
 
Cardiovascular        Normal        Abnormal; specify: 
______________________________________ 
 
Gastrointestinal        Normal        Abnormal; specify: 
______________________________________ 
 
Urogenital        Normal        Abnormal; specify: 
______________________________________ 
 
Musculoskeletal       Normal        Abnormal; specify: 
______________________________________ 
 
Failure to thrive (FTT)?         Yes        No 
 
 
 
 
 
 
________________________________________________________________________________________________________________
__ 
Name     Signature 
 
 
Study Team Member Code 
 
   
Study Team Member Code 
 
   
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DIAGNOSTIC VISIT (continued) 
 
 
Chest radiograph (A-P)      Date:   __ __ / __ __ / __ __ __ __                                           
                  d d          m m             y y y y 
 
  Normal       
  Abnormal, TB      
  Abnormal, not TB     
Impression 
 
Apex:  
 
 
 
 
 
Hilar: 
 
 
 
 
 
Mid-zone: 
 
 
        Right                  Left 
 
 
Lower zone: 
 
 
 
 
 
NOTES: 
____________________________________________________________________________ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
 
_________________________________________________________________________________
__ 
Name     Signature     Date 
 
 
 
 
 
 
 
 
 
 
Study Team Member Code 
 
   
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DIAGNOSTIC VISIT (continued) 
 
If the chest X-ray result is ‘Abnormal, TB’, then fill the following section otherwise, check ‘Not 
applicable’ and fill the diagnostic visit summary form at the end.  
 
 
Sputum Smear       Not applicable 
 
 
1 of 2:  Sputum  
                                                    
 Date obtained:   __ __ / __ __ / __ __ __ __                    
                              d d        m m             y y y y 
 
 
__                    Natural                      
            Induced 
 
Consistency:    
   Salivary 
   Mucoid  
   Muco purulent 
   Blood stained 
    
Result:                
             Positive; specify:         
       Scanty        
       1+  
                   2+           
       3+     
             Negative 
  
 
NOTES:   
___________________________________________________________________________ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
 
__________________________________________________________________________________
__   
Name                              Signature     Date   
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DIAGNOSTIC VISIT (continued) 
 
 
2 of 2:  Sputum  
                                                    
 Date obtained:   __ __ / __ __ / __ __ __ __                    
                              d d        m m             y y y y 
   
 
   Natural                       
   Induced 
 
Consistency:    
   Salivary 
   Mucoid  
   Muco purulent  
   Blood stained 
    
Result:                
             Positive; specify:         
       Scanty            
       1+            
       2+           
       3+     
             Negative 
  
 
NOTES:   
___________________________________________________________________________ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
 
__________________________________________________________________________________
__   
Name                              Signature     Date   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
102 
 
   DIAGNOSTIC VISIT (continued) 
 
CULTURE     
  
      
1 of 2:  Sputum                            
 
 Date obtained:   __ __ / __ __ / __ __ __ __        
                                d d        m m             y y y y 
 
   Positive 
    Negative           
    Contaminated 
 
If culture result is positive, record speciation.  Otherwise, check Not applicable.       
 
    Not applicable  (Check if culture was negative; Do not complete below.)   
   
    HAIN:    
   
     MTB     Positive          Negative        
    MOTT       Positive          Negative           
  
     BCG disease     Positive          Negative          
   
    
  
If culture result is MTB positive, record drug sensitivities.  Otherwise, check Not applicable.      
 
    Not applicable  (Check if culture was MTB  negative or contaminated; Do not complete below.)   
 
Drug sensitivities: 
 
  Streptomycin    Sensitive         Resistant       
   Isoniazide    Sensitive         Resistant       
   Rifampicin    Sensitive         Resistant       
  Ethambutol    Sensitive         Resistant       
 
 
NOTES:   
___________________________________________________________________________ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
 
__________________________________________________________________________________
__   
Name                              Signature     Date   
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DIAGNOSTIC VISIT (continued) 
 
 
CULTURE     
  
      
2 of 2:  Sputum                                     
 
 Date obtained:   __ __ / __ __ / __ __ __ __        
                               d d        m m             y y y y 
 
    Positive 
    Negative           
    Contaminated 
 
If culture result is positive, record speciation.  Otherwise, check Not applicable.       
 
    Not applicable  (Check if culture was negative; Do not complete below.)   
   
    HAIN:    
   
     MTB     Positive          Negative        
    MOTT       Positive          Negative           
  
     BCG disease     Positive          Negative          
   
    
  
If culture result isMTB positive, record drug sensitivities.  Otherwise, check Not applicable.      
 
    Not applicable  (Check if culture was MTB negative or contaminated; Do not complete below.)   
 
Drug sensitivities: 
 
  Streptomycin    Sensitive         Resistant       
   Isoniazide    Sensitive         Resistant       
   Rifampicin    Sensitive         Resistant       
  Ethambutol    Sensitive         Resistant       
 
 
NOTES:   
___________________________________________________________________________ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
 
__________________________________________________________________________________
__   
Name                              Signature     Date   
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DIAGNOSTIC VISIT (continued) 
 
 
Instructions for blood draw: 
  
• A blood draw of 29 ml would occur at the time of TB diagnosis, for those diagnosed with 
TB, provided that it was at least three months since the previous blood draw.   
• Participants may have additional 10 ml blood drawn as part of the tuberculosis diagnostic 
process to assess clinical parameters prior to starting treatment (e.g., CBC or serum 
chemistry).  
 
Is a blood draw required for participant? 
 
                   Yes, check if      29 ml 
             10 ml  
              both 29 ml and 10 ml     
                                                                   No, Do not complete the following section   
 
 
(To be filled by Staff Nurse only) 
 
Date of blood draw:___ ___/ ___ ___/ ___ ___ ___ ___    Or        Not applicable  
                                  dd                mm     yyyy       
 
Time of blood draw (use 24 hour clock): ___ ___ : ___ ___ 
                     hh     mm 
Blood Draw for Research of Immunology of TB  
Blood should be collected and labeled as per instruction. Not more than two trails should be made for the blood 
draw.  
 
 Number of CPT tubes used for blood collection: 
 Check ‘Not applicable’ if only 10 ml blood has to be collected 
 
        1 
        2 
        3 
        Not applicable 
      
If the number of tubes is less than 3 fill the Protocol Deviation Form. CPT tubes should be kept in the 
cool box to maintain temperature at 2-8°C and transport to the Lab within 4 hours from the time of collection. 
 
Blood collected for clinical parameters assessment: 
                                                                      
                                                      Yes     
                                                                   No 
                   Not applicable 
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Summary of Diagnostic Process                  Date:   __ __ / __ __ / __ __ __ __ 
                                                           d d        m m             y y y y 
 
TB medication   
One-week supply given      Yes        No       Not applicable 
 
Treatment started prior to discharge    Yes        No       Not applicable 
 
If medication supply is given, or if treatment has been started prior to discharge, inform zone supervisor in 
order to record on TB Treatment Record. 
 
Follow-up Letters 
Parent(s) or guardian will be provided a letter with all known test results (e.g., CXR, initial smear result) and 
an explanation of their meaning, and instructions to contact the family doctor or local health clinic for follow-
up if child was diagnosed with TB.  The letter will indicate that a follow-up letter will then be sent if any results 
are pending; a follow-up letter will then be sent to the parent(s) with the remaining results (e.g., culture) and 
diagnosis.  
 
If the parent has specified a primary care doctor, letter(s) will also be sent to the doctor at the same time of the 
letter(s) sent to the parent(s).    
 
Only if the child is diagnosed with TB, the local TB officer will receive a letter describing the diagnostic results, 
the diagnosis, and treatment recommendation.  
 
Letter sent / provided to: 
    Parent:  Initial              Yes                 No; reason ________________      
    Follow-up          Pending          Not applicable 
  
Primary care doctor: Initial        Yes                           Not applicable 
           Follow-up         Pending          Not applicable 
 
Local TB officer (upon diagnosis)    Yes      Pending       Not applicable 
   
 
 
DIAGNOSTIC PROCESS 
SUMMARY:_________________________________________________ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________
__ 
 
__________________________________________________________________________________
__   
Name                              Signature     Date   
Study Team Member Code 
 
   
106 
 
 
TB TREATMENT RECORD 
 
   
  Check if TB treatment is NEVER GIVEN to the adolescent during the entire 2-year study 
period.  If treatment is given, complete the information below.  Use an additional TB Rx 
form if necessary.  
 
 
 Treatment  
 
Record one drug per line using  
full generic name.   
Start date 
 
dd mm yyyy 
Stop date 
 
dd mm yyyy 
Treatment prescribed 
by  
Record role and affiliation, 
and name if known 
Record treatment started PRIOR to admission to Diagnostic visit in this section. 
1     
2     
3     
4     
5     
6     
Record treatment started AFTER Diagnostic visit in this section. 
1     
2     
3     
4     
5     
6     
 
Treatment Outcome (Check one.)      
  Cured  
  Treatment completed  
  Died 
  Failure  
  Defaulted  
  Transferred out 
 
 
NOTES: 
____________________________________________________________________________ 
__________________________________________________________________________________
__ 
__________________________________________________________________________________________
__ 
 
__________________________________________________________________________________
__   
Name                              Signature     Date   
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